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Abstract 
 
We have achieved a highly stereoselective and efficient total synthesis of trans-
dihydronarciclasine from a readily available chiral starting material. Our scheme defines 
two of the five stereogenic centers of the natural product by an amino acid ester-enolate 
Claisen rearrangement. The other three stereogenic centers are created in a highly 
stereocontrolled fashion via a six-membered-ring vinylogous ester intermediate, which is 
generated from the γ,δ-unsaturated ester functional group of Claisen rearrangement 
product in an efficient three-step sequence. This concise total synthesis exemplifies the 
use of a highly regioselective Friedel-Crafts-type cyclization to form the B-ring via an 
isocyanate intermediate derived from an N-Boc group, which is superior to the 
conventional method using an imino triflate intermediate. This mild and regioselective 
reaction conditions are also applicable for synthesis of various substituted isoquinolin-1-
ones, β-carbolines, thiophen fused ring systems and tetrahydrobenzoazepin-1-ones. Acid 
additives, such as BF3·Et2O, extend the application of the method to substrates bearing 
less nucleophilic aryl moieties by enhancing the Friedel-Crafts-type cyclization of 
isocyanate intermediates. 
 
Key word: Acid-mediated cyclization, Antitumor agents, Ireland-Claisen rearrangement, 
Natural products, Total synthesis 
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I. Introduction 
 
Based on their potent and selective anticancer activity as well as their unique structural 
features, Amaryllidaceae isocarbostyril alkaloids have been an attractive synthetic target 
for the last two decades.1,2 Some representative members of this class of natural products 
are trans-dihydronarciclasine (1, Figure 1), pancratistatin (2), lycoricidine (3), and 
narciclasine (4). These natural isocarbostyrils exhibit potent cytotoxicity in the NCI 60 
human tumor cell line panel with GI50 values in the nanomolar range.3 Although trans-
dihydronarciclasine has far greater anticancer activity than the intensively investigated 
pancratistatin (2) and other congeners,3b less effort has been devoted to biological and 
synthetic studies on trans-dihydronarciclasine until recently.4 
The isolation of (+)-1 from the Chinese medical plant Zephyranthes candida was 
reported in 1990.5 Interestingly, it was produced synthetically long before its isolation 
from natural sources, through hydrogenation of narciclasine (4) with low 
diastereoselectivity.6 The first total synthesis of the racemate was reported by Cho in 
2007,4a which involved a Diels-Alder cycloaddition of 3,5-dibromo-2-pyrone for the 
preparation of functionalized C-ring. The first enantioselective synthesis by Studer 
appeared in 2008,4b in which the required absolute stereochemistry of C-ring was 
introduced by a Cu-catalyzed enantioselective nitroso Diels-Alder reaction. Both 
syntheses employed Banwell’s modified Bischler-Napieralski reaction at a late stage of 
the sequence for closure of the B-ring. 
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Figure 1. Chemical structures of compounds 1−4. 
 
Herein, we wish to describe a short and highly stereocontrolled total synthesis of (+)-1 
by a strategy that is unique as compared to other previous syntheses of Amaryllidaceae 
isocarbostyril alkaloids. Our route is characterized by the use of an N-Boc group first to 
steer the stereochemical course of a Claisen rearrangement, and then to generate an 
isocyanate intermediate for a highly regioselective Friedel-Crafts-type B-ring cyclization. 
This approach is superior to using the conventional Bischler-Napieralski-type B-ring 
cyclization, especially in the sense of regioselectivity. 
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II. Results and Discussion 
 
II-1. Retrosynthetic Analysis 
 
As shown in Scheme 1, we planned to construct the B-ring of 1 at a late stage of the 
synthesis, similarly to many other Amaryllidaceae isocarbostyril synthetic approaches. 
We envisioned construction of the B-ring could be achieved by utilizing the N-Boc 
carbamate group in 5, where this group is also essential for attaining high stereocontrol in 
the subsequent transformations (vide infra). Our strategy was premised on the selective 
transformation the β-keto enol ether function of 6 to the three contiguous hydroxyl groups 
in the C-ring of 5. We expected that cyclic vinylogous ester 6 could be obtained 
regioselectively from the γ,δ-unsaturated ester 7 via regioselective Wacker oxidation, 
Dieckmann condensation, and regioselective vinylogous ester formation. We further 
envisioned that an ester enolate Claisen rearrangement of the Boc-protected amino acid 
allylic ester 8 would provide the γ,δ-unsaturated α-amino ester 7.7 In this transformation, 
the required stereochemistry of the two contiguous stereocenters at C-4a and C-10b could 
be installed with chirality transfer from a preformed chiral center in substrate 8 via a 
chair-like transition state. The Boc group was chosen as the amino protecting group 
because the stereoselectivity of ester enolate Claisen rearrangements of Boc-protected 
amino esters is generally superior to that of other carbamate-protected amino esters.8 In 
addition, the bulkiness of the Boc group was expected to promote high reaction 
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selectivity through steric interactions or conformational reinforcement, especially in the 
introduction of the three contiguous hydroxyl group stereocenters. 
 




II-2. A-C Ring System Synthesis 
 
As illustrated in Scheme 2, the synthesis was initiated by preparing Claisen substrate 8 
from the enantiomerically enriched allylic alcohol 9. The synthesis of 9 from the aryl 
bromide 10 and chiral building block (R)-11 (>99% ee) was previously reported by us in 
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the total synthesis of 2.9 Allylic alcohol 9 was then coupled with N-Boc-glycine to 
provide the chiral allylic amino acid ester 8. After some experimentation, we identified 
conditions that led to the formation of the desired rearranged product 12 in excellent 
stereoselectivity and yield. Deprotonation of 8 at −78 oC with LHMDS in THF in the 
presence of TBSCl resulted in the formation of the intermediate (Z)-silyl ketene acetal, 
which underwent Claisen rearrangement upon gradual warming to room temperature to 
afford 12 (93%) after treatment with TMS-diazomethane.10 A single diastereomer was 
observed by NMR and HPLC analysis. The absolute configurations of the two new 
stereocenters were assumed to be 4aR and 10bR by invoking chair transition state A for 
the rearrangement, and these configurations were ultimately confirmed through 
conversion to the final natural product. 
Efforts were next directed toward forming the C-ring by a two-step process that began 
with regioselective oxidation of the internal olefin to afford methyl ketone 13. The 
resulting intermediate could then undergo Dieckmann condensation to give cyclic β-
diketone 14. In the event, highly regioselective (8:1) Wacker oxidation of olefin 12 could 
be achieved in 82% yield with Pd(OAc)2 and benzoquinone (BQ).11 Condensation of 13 
using t-BuOK in THF provided the desired β-diketone 14, which was used directly in the 








II-3. C-Ring Functionalization 
 
Our approach to functionalize the C-3 position was to convert cyclic β-diketone moiety 
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of 14 to the corresponding vinylogous ester by enol etherification. The regiochemical 
outcomes of etherification of asymmetric cyclic β-diketones are often difficult to predict, 
and mixtures of the two possible products are frequently produced.13 However, we 
envisioned that enol etherification of 14 would be regioselective under thermodynamic 
conditions, since vinylogous ester 15 was expected to be thermodynamically more stable 
than its regioisomer 16 primarily due to the lower steric strain. Some support was 
obtained from our computational modeling studies, which predicted that 15b would be 
more stable than 16b by 1.36 kcal/mol.14 As expected, treatment of crude 14 with benzyl 
alcohol and a catalytic amount of camphorsulfonic acid in toluene at 80 °C led to the 
selective formation of vinylogous benzyl ester 15a (64% yield from 13), along with a 
minor amount of its regioisomer 16a (6:1). 16a could be recycled by chromatographic 
separation followed by resubjection to the above etherification conditions to isomerize it 
back to the 6:1 mixture in favor of 15a.15 
Next, our study focused on the selective conversion of the β-keto enol ether function of 
15a into a triol (Scheme 3). First, the carbonyl group of 15a was stereoselectively 
reduced with Red-Al to give exclusively the required 4β-hydroxy group. Since allylic 
alcohol 17 was unstable,13c,16 it was immediately used in the next step without 
chromatographic purification. Dihydroxylation of the enol ether 17 under the Upjohn 
dihydroxylation conditions (OsO4, NMO)17 afforded exclusively the undesired C3-α 
stereoisomer (79% from 15a) instead of 18. Even under the hydroxy-directed 
dihydroxylation conditions of Donohoe,18 the same undesired isomer was formed (76%).  
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Scheme 3. Introduction of the stereocenters in the C ring. 
 
 
On the other hand, epoxidation of the enol ether 17 by using m-CPBA or 
VO(acac)2/TBHP system19 did occur on the desired β-face of the molecule to produce the 
α-hydroxy ketone 18 with the desired C3 stereochemistry, but in a disappointingly low 
yield (<5%). To overcome the problem of low yield, the domino epoxidation-
methanolysis protocol was employed.20 Epoxidation with m-CPBA in MeOH in the 
presence of NaHCO3 provided mixed ketal 19 as a single diastereoisomer in 82% yield (2 
steps) from 15a. Since α-hydroxy ketals are prone to rearrange under acidic conditions,21 
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the deketalization of 19 was effected gently by catalytic hydrogenation of the benzyl 
group to give ketone 18. Dihydroxyketone 18 itself was also found to be unstable,22 and 
readily decomposed to unidentified polar material. Thus, the best approach was to treat 
crude ketone 18 directly with the sterically demanding L-Selectride to give triol 20 as the 
sole stereoisomer in 92% overall yield from 19.23 Triol 20 was then protected to give 
triacetate 21 (92%). 
 
 
II-4. B-Ring Construction under Banwell’s Modified Bischler-
Napieralski Reaction Conditions 
 
After completing the functionalization of the C-ring, we turned our attention to the 
construction of the B-ring to complete the total synthesis. Banwell’s modified Bischler-
Napieralski reaction,24 which is thought to proceed via an imino triflate intermediate, has 
been used widely for closure of the B-ring in the synthesis of Amaryllidaceae alkaloids 
including trans-dihydronarciclasine (1) and pancratistatin (2). However, literature 
examples of this reaction show it only to be effective for primary alkyl carbamate 
substrates.2c-e Thus, we were uncertain at that time that the Banwell procedure would be 
applicable to B-ring formation using the N-Boc group in our case. 
Under the standard Banwell’s reaction conditions (Tf2O/DMAP = 5/3 molar ratio, 0 °C), 
we were able to obtain the desired cyclization product 22 along with a minor amount of 
 9 
the regioisomer 23 from the N-Boc carbamate 21, but in a very low yield (38%) (Scheme 
4). Interestingly, although the chemical yield was much lower (38% vs. 82%), the degree 
of regioselectivity in the B-ring formation was considerably higher than in the reported 
case in which Banwell’s modified Bischler-Napieralski reaction conditions were applied 
to the corresponding methoxycarbonyl compound 24 (11.5:1 vs. up to 3.6:1).4a,b This 
remarkable regioselectivity difference between the cyclization of substrate 21 and 24 
under the same reaction conditions implied that the two cycloaddition reactions might 
proceed via different intermediates. 
 
Scheme 4. B-ring construction under Banwell’s reaction conditions. 
 
 
Recently, Schofield and co-workers have observed that upon treatment with 2.0 equiv of 
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Tf2O and 2.2 equiv of Et3N or pyridine, N-Boc protected phenylalanine ester underwent 
dimerization to form a urea, most probably via an isocyanate intermediate.25 This 
observation suggested the possibility that under Banwell’s acidic reaction conditions, the 
N-Boc carbamate of 21 was converted to an isocyanate through loss of its acid-labile t-
butyl group and dehydration, and this in situ generated isocyanate underwent 
intramolecular Friedel-Crafts-type cyclization. Although there have been several reports 
of isocyanates being used in Friedel-Crafts-type cyclization,26 no examples of the 
intramolecular Friedel-Crafts capture of an isocyanate intermediate generated from N-Boc 
carbamates have been reported.27 Isocyanates could be prepared by several methods, such 
as from an amine by treatment with phosgene26a or its equivalent including 
(Boc)2O/DMAP,26b from an acid or amide utilizing Curtius or Hoffmann 
rearrangement,26c,d and from a carbamate by treatment with dehydrating reagents.28 
However, only a few examples of the direct conversion of N-Boc carbamate to an 
isocyanate have been reported.28a,b  
 
 
II-5. Model studies and Optimization of B–Ring Construction 
 
Based on the observation of Schofield and our initial results under Banwell’s reaction 
conditions, our studies began with the reagent combination of Tf2O and base for Friedel-
Crafts-type reactions of N-Boc carbamate substrates via isocyanate intermediateds. N-Boc 
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carbamate 25 (Scheme 5) was chosen as an initial model substrate. Before identifying the 
optimal reaction conditions for our purposes, we first examined the chemical behavior 
differences between N-Boc carbamate substrate 25 and the corresponding N-Moc 
substrate 26 under Banwell’s modified Bischler-Napieralski reaction conditions (Scheme 
5). Under the Banwell conditions, N-Boc substrate 25 provided dihydroisoquinolinone 27 
along with the minor regioisomeric product 28 in 42% combined yield and 12.2:1 
regioselectivity. On the other hand, the N-Moc substrate 26 provided a methyl imidate 29, 
which upon hydrolysis with 3 M HCl afforded 27 and 28 in a higher combined yield 
(83%) but with much lower regioselectivity (3.9:1). These results are very similar to those 
observed for the corresponding, more complex substrates 21 and 24. 
 
Scheme 5. Model Studies of B-ring Construction 
 
 
When DMAP in Banwell’s reagent combination was replaced by the less basic pyridine 
and 2-chloropyridine,29 N-Boc carbamate 25 provided 27 and 28 as well as their N-
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triflated derivatives 30 and 31 (Table 1, entries 2 and 3). The combined yield of cyclized 
products was increased, and the high regioselectivity was maintained (entries 2 and 3 vs. 
entry 1). To avoid the N-triflation caused by excess Tf2O,30 the amount of Tf2O was 
reduced to 1.5 equiv. In this case, isocyanate 32 was rapidly formed (within 20 min) as 
the only detectable reaction product and exhibited prolonged stability without conversion 
into dihydroisoquinolinones (entry 4). The identification of isocyanate 32 strengthened 
our belief that an N-Boc carbamate substrate could be transformed into a 
dihydroisoquinolinone via an isocyanate intermediate. The addition of excess Lewis acid 
(10 equiv) to the reaction mixture containing isocyanate 32 to facilitate the Friedel-Crafts 
reaction led to the formation of dihydroisoquinolinones 27 and 28 without the formation 
of the N-triflated derivatives (entries 5, 6, and 7). The yields from this stepwise process 
were much improved compared to that under the Banwell conditions (85–90% vs. 42%), 
although the degree of regioselectivity was slightly lower (8.5:1–9.7:1 vs. 12.2:1). 
The above results implied that the reaction process was greatly influenced by the amount 
of base present and the acidity of the reaction medium. By further changing the molar 
ratios of Tf2O and 2-chloropyridine, we finally determined the optimal reaction 
conditions for 25 to be 1.1 equiv of Tf2O, 1.5 equiv of 2-chloropyridine and heating at 35 
ºC for 20 h. Under these conditions, N-triflation was minimized, and the product 27 was 




Table 1. Optimization of Friedel-Crafts-type cyclizationa 
 
Entry Tf2O (eq) Base (eq) Lewis acid t (h) Yield (%)b,c (27+30): (28+31)d 
1 5.0 DMAP (3.0) – 20 42 12.2:1 
2 5.0 Py (3.0) – 20 21+(45) 12.1:1 
3 5.0 2-ClPy (3.0) – 20 44+(40) 12.4:1 
4 1.5 2-ClPy (3.0) – 20 – – 
5e 1.5 2-ClPy (3.0) BF3∙Et2O 2 86 8.5:1 
6e 1.5 2-ClPy (3.0) MsOH 0.5 90 8.5:1 
7e 1.5 2-ClPy (3.0) TfOH 0.5 85 9.7:1 
8f 1.1 2-ClPy (1.5) – 20 82 12.3:1 
aReaction conditions: 25 (0.3 mmol), Tf2O, base, CH2Cl2 (10 mL), 0 ºC for 0.5 h and then rt. bIsolated yield 
of the mixture of 27 and 28. The values in parentheses are the isolated yield of the mixture of 30 and 31. 
cEach regioisomer could be separated. dDetermined by 1H NMR analysis. eLewis acid was added after the 
formation of isocyanate. fReaction was conducted at –78 ºC for 0.5 h and then at 35 ºC for 20 h. 
 
Using the optimized reaction conditions with or without an acid additive, we next 
investigated the scope of substrates (Table 2). All substrates were first subjected to the 
reaction conditions without an acid additive (Method A: Tf2O (1.1 equiv), 2-ClPy (1.5 
equiv), –78 ºC to rt). If method A gave unsatisfactory results, the Lewis acid was added 
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after the formation of isocyanate to facilitate the Friedel-Crafts reaction (Method B: Tf2O 
(1.1 equiv), 2-ClPy (1.5 equiv), then BF3·Et2O (5.0 equiv), –78 ºC to rt). The results are 
summarized in Table 2. Remarkably, the cyclizations of all compounds bearing electron-
rich aryl rings proceeded in high yield and with high or exclusive regioselectivity. 
The N-Boc carbamate 33a bearing a trimethoxy-substituted benzene ring as a 
nucleophilic moiety was easily transformed to 3,4-dihydroisoquinolin-1-one 34a using 
method A in 71% yield (entry 1). The 3,4-dimethoxy substituted substrate 33b also 
afforded the cyclized product 34b in high yield (87%) using method A with very high 
regioselectivity (>20:1) (entry 2). However, substrates 33c and 33d required the addition 
of BF3·Et2O for cyclization (entries 3 and 4) to give products. High yield and 
regioselectivity were also observed. The Lewis acid requirement for these substrates 
might be due to the lower nucleophilicity of their aryl ring moieties compared to that of 
the electron-rich substrates 33a and 33b.31 Substrates with electron-deficient or neutral 
groups at the aryl moiety did not undergo the cyclization reaction under either set of 
reaction conditions, yielding only the corresponding isocyanates (entries 5 and 6). 
The phenyl rings could also be replaced by heteroarene units. Electron-rich heterocycles, 
such as indole and N-methyl indole moieties, showed good cyclization efficiency to 
afford tetrahyrdo-β-carbolin-1-ones 34g and 34h in good yield (70% and 92%, 
respectively) (entries 7 and 8). With the aid of an acid additive, thiopen substrate 33i also 
produced the cyclized product 34i in 79% yield (entry 9). 
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Table 2. Substrate Scope of the Reactions 
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aMethod A: Tf2O (1.1 equiv), 2-ClPy (1.5 equiv), CH2Cl2, –78 ºC to rt. Method B: Tf2O (1.1 equiv), 2-ClPy 
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(1.5 equiv), BF3·Et2O (5.0 equiv), CH2Cl2, –78 ºC to rt. bIsolated yield. cRegioisomeric mixture (18:1). 
dLactam product was not detected. eTfOH was used instead of BF3·Et2O. 
 
The substrate for which the N-Boc carbamate group is bonded directly to an aromatic 
ring also provided the cyclized product (entries 10 and 11). The 3,5-dimethoxy 
substituted substrate 33j smoothly afforded phenanthridone 34j in high yield (81%) under 
method A. However, the 3,4-dimethoxy substituted substrate 33k required the addition of 
the Lewis acid for cyclization and provided phenanthridone 34k in a slightly lower yield 
(70%). 
We also explored the feasibility of forming a five- or seven-membered ring lactam using 
these methods. Attempts to generate the dihydro-isoindolone 34l, from the reaction of 
substrate 33l under the above conditions produced complicated unidentified mixtures 
(entry 12).32 However, under acid-induced conditions, γ-arylpropylcarbamate 33m could 
be transformed into the benzo[c]azepin-1-one 34m in 83% yield (entry 13). 
 
 
II-6. Final Stages and Completion of the Synthesis  
 
By applying these optimized conditions to N–Boc carbamate 21, we were able to obtain 
the desired cyclization product 22 with very high regioselectivity (12.5:1) in 76% yield 
(Scheme 6). After careful monitoring of the reaction of 21, we could identify a somewhat 
unstable isocyanate intermediate 35 and its identity was mainly confirmed by IR 
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spectroscopy (2253 cm–1). The total synthesis was completed by demethylation with 
TMSCl/KI (75%) and removal of the acetate protecting groups with NaOMe (95%) to 
give (+)–1. The spectroscopic and optical rotation data of the synthetic material were in 
good agreement with those reported for the natural product. 
 






In conclusion, the total synthesis of (+)-trans-dihydronarciclasine (1) has been 
accomplished in 16% overall yield in a completely substrate-controlled manner from the 
readily accessible chiral starting material 9. One of the unique features of this synthesis is 
the highly stereocontrolled introduction of the five contiguous stereogenic centers based 
on a single stereocenter in starting material. Two of the five stereocenters were defined by 
an Ireland-Claisen rearrangement, and the other three centers were created through 
diastereoselective reduction and oxidation reactions. The stereoselectivity for introducing 
all of the stereogenic reactions was excellent, with only a single diastereomer of each 
product being observed. The concise nature of this total synthesis hinges in part on the 
first demonstration of the successful conversion of a Claisen rearrangement product into a 
six-membered cyclic vinylogous ester via a regioselective Wacker oxidation and 
Dieckmann condensation based sequence. The successful B-ring formation with high 
regioselectivity from an N-Boc substrate via an isocyanate intermediate is also quite 
noteworthy, and the present transformation is a useful complement to Banwell’s variant 






IV-1. General.  
 
All chemicals were of reagent grade and used as received. All reactions were performed 
under an inert atmosphere of dry nitrogen using distilled dry solvents. Reactions were 
monitored by TLC analysis using silica gel 60 F-254 thin layer chromatography plates. 
Flash column chromatography was carried out on silica gel (230-400 mesh). Optical 
rotations were measured using sodium light (D line 589.3 nm). 1H NMR (300, 400 or 500 
MHz) and 13C NMR (75, 100 or 125 MHz) spectra were recorded in δ units relative to the 
non-deuterated solvent as the internal reference. IR spectra were measured on a Fourier 
Transform Infrared spectrometer. Mass spectra (MS) and high resolution mass spectra 
(HRMS) were recorded using fast atom bombardment (FAB). 
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IV-2. Experimental procedure and spectroscopic data analysis 
 
IV-2.1. All the compounds of the total synthesis process 
 
(R,E)-4-(7-methoxybenzo[d][1,3]dioxol-5-yl)but-3-en-2-yl 2-(tert-butoxycarbonyl 
amino)ace tate (8): 
 
To a solution of allylic alcohol 99 (3.50 g, 15.75 mmol, 1.0 equiv) in CH2Cl2 (80 mL) 
were added N-Boc-glycine (3.31 g, 18.90 mmol, 1.2 equiv), DMAP (383 mg, 3.15 mmol, 
0.2 equiv), and DCC (3.90 g, 18.90 mmol, 1.2 equiv) at 0 °C. The reaction mixture was 
stirred for 2 h at room temperature followed by dilution with hexane. The generated white 
precipitate was removed by filtration through a pad of Celite and the filtrate was 
concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (hexane/EtOAc, 2:1) to give allylic amino acid ester 8 (5.91 
g, 99%) as a pale yellow oil. [α]25D +84.7 (c = 2.15, CHCl3); 1H NMR (400 MHz, CDCl3): 
δ = 1.37 (d, J = 6.5 Hz, 3H), 1.40 (s, 9H), 3.85 (s, 3H), 3.85−3.86 (m, 2H), 5.09 (br s, 1H), 
5.50 (pent, J = 6.5 Hz, 1H), 5.90 (s, 2H), 5.96 (dd, J = 6.9, 15.8 Hz, 1H), 6.45 (d, J = 16.0 
Hz, 1H), 6.48 (s, 1H), 6.55 ppm (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 20.25, 28.16 
(3C), 42.56, 56.39, 72.15, 79.76, 99.99, 101.43, 106.90, 126.72, 130.91, 131.87, 135.18, 
 21 
143.43, 149.02, 155.61, 169.57 ppm; IR (CHCl3): υmax = 3399, 2979, 1713, 1627, 1510, 
1431, 1368 cm-1; MS (FAB): m/z: 379 [M]+; HRMS (FAB): m/z calcd for C19H25NO7: 





To a stirred solution of ester 8 (5.00 g, 13.18 mmol, 1.0 equiv) in THF (80 mL) was 
added TBSCl (5.96 g, 39.54 mmol, 3.0 equiv) in THF (8 mL). After the mixture was 
cooled to –78 oC, LHMDS (1.0 m soln. in THF, 40 mL, 39.54 mmol, 3.0 equiv) was 
slowly added to the reaction flask over 30 min. The reaction mixture was slowly warmed 
to room temperature and stirred for 20 h. The reaction was quenched with saturated 
NH4Cl solution at 0 oC, stirred for another 1 h at room temperature, and then the mixture 
was extracted twice with EtOAc. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated under reduced pressure to give the desired acid 12-
acid as a single isomer, which was used in the next step without further purification. A 
small amount of pure acid was isolated by column chromatography on silica gel 
(hexane/EtOAc, 2:1 + 1% AcOH) for 1H NMR and HRMS analysis. 1H NMR (400 MHz, 
CD3OD): δ = 1.33 (s, 9H), 1.65 (d, J = 5.9 Hz, 3H), 3.52 (t, J = 8.6 Hz, 1H), 3.85 (s, 3H), 
 22 
4.34 (d, J = 8.8 Hz, 1H), 5.50−5.58 (m, 1H), 5.60−5.67 (m, 1H), 5.86 (d, J = 3.4 Hz, 2H), 
6.42 (s, 1H), 6.44 ppm (s, 1H); MS (FAB): m/z: 402 [M+23]+; HRMS (FAB): m/z calcd 
for C19H25NO7: 379.1631 [M]+; found: 379.1655. 
The crude mixture obtained above was dissolved in MeOH (44 mL), and trimethylsilyl-
diazomethane solution (2.0 m soln. in diethyl ether, 17 mL, 32.95 mmol, 2.5 equiv) was 
added dropwise, causing instantaneous bubbling, along with a change from colorless to 
yellow. After allowing the reaction to proceed for 1 h, the reaction was quenched with 
small amount of acetic acid, at which time gas evolved and the reaction mixture became 
colorless. The solvent was removed in vacuo, and the residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 4:1) to give the desired ester 12 
(4.82 g, 93% for 2 steps) as a pale yellow solid. [α]25D −45.2 (c = 0.88, CHCl3); 1H NMR 
(500 MHz, CDCl3): δ = 1.38 (s, 9H), 1.67 (d, J = 5.1 Hz, 3H), 3.54−3.50 (m, 1H), 3.66 (s, 
3H), 3.87 (s, 3H), 4.50 (t, J = 7.3 Hz, 1H), 4.78 (d, J = 7.6 Hz, 1H), 5.54−5.63 (m, 2H), 
5.92 (s, 2H), 6.31 (s, 1H), 6.36 ppm (d, J = 1.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ = 
17.81, 28.02 (3C), 51.16, 51.71, 56.44, 57.76, 79.77, 101.23, 101.80, 107.36, 128.24, 
128.87, 133.95, 134.10, 143.38, 148.88, 155.07, 172.02 ppm; IR (CHCl3): υmax = 3377, 
2976, 1744, 1715, 1634, 1510, 1452 cm-1; MS (FAB): m/z: 394 [M+1]+; HRMS (FAB): 
m/z calcd for C20H28NO7: 394.1866 [M+H]+; found: 394.1972. 
The diastereomeric purity of ester 12 was determined by crude 1H NMR spectrum 
analysis. The enantiomeric purity of ester 12 (>99%ee) was determined by chiral HPLC 
analysis (CHIRALCEL OJ-H, 2-propanol/hexane (0 to 10%, 60 min), flow rate: 0.5 
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mL/min, tR: (chiral sample) = 37.7 min [(–)-isomer]; tR (racemic sample) = 37.1 [(–)-





To a mixture of Pd(OAc)2 (685 mg, 3.05 mmol, 0.3 equiv) and 1,4-benzoquinone (1.10 
g, 10.17 mmol, 1.0 equiv) in MeCN/H2O (7:1, v/v, 51 mL) was added HClO4 (1.0 m soln. 
in MeCN, 2.0 mL, 2.03 mmol, 0.2 equiv). The resulting solution was stirred 1 h at room 
temperature and ester 12 (4.00 g, 10.17 mmol, 1.0 equiv) was added to reaction flask. 
After being stirred for 6 h at room temperature, the reaction was quenched with saturated 
NaHCO3 solution at 0 oC and then the mixture was extracted twice with EtOAc. The 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo. Due to similar Rf values for the hydroquinone generated and the product under 
various eluent conditions, hydroquinone was acetylated under standard conditions (Ac2O, 
NEt3, DMAP, CH2Cl2). The resulting crude mixture was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 2:1) to give desired methyl ketone 13 (3.41 
g, 82%) as a pale brown oil. [α]25D −55.3 (c = 0.72, CHCl3); 1H NMR (500 MHz, CDCl3): 
δ = 1.43 (s, 9H), 2.13 (s, 3H), 2.67 (dd, J = 5.4, 17.7 Hz, 1H), 2.98 (dd, J = 8.4, 17.8 Hz, 
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1H), 3.70 (s, 3H), 3.78 (br s, 1H), 3.86 (s, 3H), 4.60 (d, J = 5.0 Hz, 1H), 4.97 (d, J = 8.3 
Hz, 1H), 5.92 (s, 2H), 6.26 (d, J = 1.3 Hz, 1H), 6.31 ppm (d, J = 1.4 Hz, 1H); 13C NMR 
(125 MHz, CDCl3): δ = 28.14 (3C), 30.14, 42.25, 45.14, 52.10, 56.47, 56.58, 79.96, 
101.31, 101.64, 108.10, 133.00, 134.46, 143.30, 148.94, 155.70, 171.40, 205.80 ppm; IR 
(CHCl3): υmax = 3381, 2978, 1714, 1633, 1510, 1452, 1435 cm-1; MS (FAB): m/z: 409 





To a stirred solution of methyl ketone 13 (3.00 g, 7.33 mmol, 1.0 equiv) in THF (40 mL) 
was slowly added t-BuOK (1.0 m soln. in THF, 19 mL, 18.3 mmol, 2.5 equiv) at 0 oC. 
The reaction mixture was stirred for 30 min at 0 oC, then quenched by addition of 
saturated NH4Cl solution, and extracted twice with EtOAc. The combined organic layers 
were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to give β-





Vinylogous benzyl ester (15a and 16a): 
 
To a mixture of crude β-diketone 14 in toluene (30 mL) and benzyl alcohol (7.5 mL), 
catalytic 10-camphorsulfonic acid (170 mg, 0.73 mmol, 0.1 equiv) was added. The 
reaction mixture was stirred for 4 h at 80 oC and then quenched by the addition of NEt3 
(0.1 mL) at 0 oC. This was diluted with EtOAc, washed with brine, dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (hexane/EtOAc, 2:1) to give vinylogous benzyl ester 15a (2.19 g, 64%) and 
minor isomer 16a (377 mg, 11%) as white solids. The minor isomer 16a could be cleanly 
separated chromatographically and be isomerized back to the 6:1 mixture (combined 70% 
yield) in favor of 15a by resubjection to the above etherification conditions. Additional 
15a (226 mg) could be obtained from 16a through this isomerization. 
 
Major isomer 15a (tert-butyl (1R,6R)-4-(benzyloxy)-6-(7-methoxybenzo[d][1,3]dioxol-
5-yl)-2-oxocyclohex-3-enylcarbamate): [α]25D +21.6 (c = 0.67, CHCl3); 1H NMR (400 
MHz, CDCl3): δ = 1.30 (s, 9H), 2.66 (dd, J = 4.7, 17.5 Hz, 1H), 2.81−2.89 (m, 1H), 3.21 
(t, J = 8.6 Hz, 1H), 3.84 (s, 3H), 4.25−4.38 (m, 1H), 4.75−4.90 (m, 3H), 5.55 (s, 1H), 
5.87 (d, J = 2.3 Hz, 2H), 6.42 (s, 1H), 6.45 (s, 1H), 7.29−7.36 ppm (m, 5H); 13C NMR 
(100 MHz, CDCl3): δ = 28.01 (3C), 37.65, 45.95, 56.41, 59.58, 70.86, 79.30, 101.20, 
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101.70, 101.88, 107.20, 127.63 (2C), 128.48, 128.59 (2C), 134.11, 134.54, 134.59, 
143.30, 148.65, 155.73, 174.82, 194.95 ppm; IR (CHCl3): υmax = 2977, 1708, 1665, 1608, 
1514, 1453, 1364 cm-1; MS (FAB): m/z: 468 [M+1]+; HRMS (FAB): m/z calcd for 
C26H30NO7: 468.2022 [M+H]+; found: 468.2010. 
 
Minor isomer 16a (tert-butyl (1R,6R)-2-(benzyloxy)-6-(7-methoxybenzo[d][1,3]dioxol-
5-yl)-4-oxocyclohex-2-enylcarbamate): 1H NMR (500 MHz, DMSO-d6): δ = 1.25 (s, 
9H), 2.36 (dd, J = 3.9, 16.1 Hz, 1H), 2.78 (dd, J = 13.4, 16.0 Hz, 1H), 3.29−3.39 (m, 1H), 
3.80 (s, 3H), 4.66 (t, J = 9.9 Hz, 1H), 4.97−5.03 (m, 2H), 5.50 (s, 1H), 5.94 (s, 2H), 6.59 





To a stirred solution of vinylogous benzyl ester 15a (2.00 g, 4.28 mmol, 1.0 equiv) in 
THF (43 mL) was slowly added Red-Al (sodium bis(2-methoxyethoxy)aluminum 
dihydride (70% in toluene, ca. 3.6 m), 1.8 mL, 6.42 mmol, 1.5 equiv) at 0 oC. The 
reaction mixture was stirred for additional 30 min, and then quenched by the addition of 
saturated NH4Cl solution at 0 oC, and extracted twice with EtOAc. The combined organic 
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layers were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to 
give allylic alcohol 17 as a single isomer.33 Due to its instability under acidic conditions, 
the resulting pale yellow oil was used in the next step without further purification. The 
diastereomeric purity of alcohol 17 was determined by crude 1H NMR spectrum analysis. 
1H NMR (300 MHz, CDCl3): δ = 1.35 (s, 9H), 2.40 (dd, J = 5.1, 16.8 Hz, 1H), 2.52 (t, J = 
16.8 Hz, 1H), 2.89 (dt, J = 5.5, 11.5 Hz, 1H), 3.69 (td, J = 7.1, 11.8 Hz, 1H), 3.89 (s, 3H), 
4.41 (br s, 2H), 4.67−4.90 (m, 3H), 5.90−6.00 (m, 2H), 6.38−6.44 (m, 2H), 7.27−7.42 





To the crude mixture of allylic alcohol 17 obtained in the previous step in MeOH (22 
mL) was added NaHCO3 (1.08 g, 12.84 mmol, 3.0 equiv) and m-CPBA (1.11 g, 6.42 
mmol, 1.5 equiv) at 0 oC. The reaction mixture was stirred for 2 h at room temperature, 
and then quenched by addition of saturated Na2S2O3 solution at 0 oC, and extracted twice 
with EtOAc. The combined organic layers were washed with brine, dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (hexane/EtOAc, 1:2) to give ketal 19 (1.82 g, 82% for 2 steps from 15a) as a 
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single isomer. [α]25D +11.8 (c = 0.51, CHCl3); 1H NMR (400 MHz, CDCl3 + D2O): δ = 
1.29 (s, 9H), 2.02 (dd, J = 2.0, 13.9 Hz, 1H), 2.12 (t, J = 13.9 Hz, 1H), 2.51 (dt, J = 3.5, 
12.5 Hz, 1H), 3.27 (s, 3H), 3.73 (dd, J = 2.5, 9.8 Hz, 1H), 3.86 (s, 3H), 3.91 (br s, 1H), 
4.13 (s, 1H), 4.38 (d, J = 7.9 Hz, 1H), 4.50 (d, J = 11.4 Hz, 1H), 4.59 (d, J = 11.4 Hz, 1H), 
5.90 (d, J = 3.2 Hz, 2H), 6.40 (d, J = 3.8 Hz, 2H), 7.26−7.38 ppm (m, 5H); 13C NMR 
(100 MHz, CDCl3): δ = 28.07 (3C), 34.95, 43.21, 47.81, 54.94, 56.46, 62.33, 70.87, 73.64, 
79.77, 100.99, 101.19, 101.97, 106.77, 127.33, 127.42 (2C), 128.26 (2C), 133.89, 135.89, 
138.08, 143.49, 148.71, 157.19 ppm; IR (CHCl3): υmax = 3398, 2973, 1691, 1635, 1515 
cm-1; MS (FAB): m/z: 518 [M+1]+; HRMS (FAB): m/z calcd for C27H36NO9: 518.2390 





To a solution of 19 (1.50 g, 2.90 mol, 1.0 equiv) in MeOH (30 mL) was added 10% 
Pd/C (450 mg, 30% wt. of 19). The flask was evacuated, filled with H2, and stirred at 
room temperature for 5 h. After this, the reaction mixture was diluted with EtOAc, 
filtered through a pad of Celite, and concentrated in vacuo to give crude mixture of 
dihydroxyketone 18. Due to its instability, resulting colorless oil was used in the next step 
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without further purification. To the crude mixture of 18 in THF (30 mL) was slowly 
added L-Selectride (lithium tri-sec-butylborohydride, 1.0 m soln. in THF, 4.4 mL, 4.35 
mmol, 1.5 equiv) at −78 oC. The reaction mixture was stirred for 30 min at -78 oC, and 
then quenched by addition of saturated NH4Cl solution at 0 oC, and extracted twice with 
EtOAc. The combined organic layers were washed with brine, dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (hexane/Acetone, 1:2) to give triol 20 (1.06 g, 92% for 2 steps from 19) as a single 
isomer. [α]25D +0.99 (c = 0.65, CH3OH); 1H NMR (400 MHz, CD3OD): δ = 1.25 (s, 9H), 
1.71 (d, J = 13.6 Hz, 1H), 2.10 (t, J = 13.2 Hz, 1H), 2.86 (t, J = 11.0 Hz, 1H), 3.34 (s, 1H), 
3.70−3.78 (m, 1H), 3.81 (s, 1H), 3.85 (s, 3H), 3.95 (s, 2H), 5.80−5.86 (m, 2H), 6.44 (s, 
1H), 6.49 ppm (s, 1H); 13C NMR (100 MHz, CD3OD): δ = 29.47 (3C), 37.08, 44.65, 
56.77, 57.89, 71.52, 73.56, 75.01, 80.34, 102.95, 103.98, 109.91, 135.68, 139.56, 145.36, 
150.76, 159.41 ppm; IR (neat): υmax = 3388, 2925, 1683, 1635, 1513 cm-1; MS (FAB): 
m/z: 397 [M]+; HRMS (FAB): m/z calcd for C19H27NO8: 397.1737 [M]+; found 397.1753. 
 
(1S,2R,3S,4R,5R)-4-(tert-butoxycarbonylamino)-5-(7-methoxybenzo[d][1,3]dioxol-
5-yl)cyclohexane-1,2,3-triyl triacetate (21): 
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To a mixture of triol 20 (700 mg, 1.76 mmol, 1.0 equiv) in CH2Cl2 (18 mL) was added 
NEt3 (2.0 mL, 14.08 mmol, 8.0 equiv), DMAP (21.5 mg, 0.176 mmol, 0.1 equiv), and 
Ac2O (0.84 mL, 8.81 mmol, 5.0 equiv) at 0 oC. After being stirred for 3 h at room 
temperature, the reaction was quenched by addition brine at 0 oC and then the mixture 
was extracted twice with CH2Cl2. The combined organic layers were washed with 
saturated NH4Cl and brine, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by flash chromatography on silica gel (hexane/EtOAc, 1:1) to give triacetate 
21 (848 mg, 92%) as a colorless oil. [α]25D +44.4 (c = 0.64, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ = 1.23 (br s, 9H), 1.90−2.02 (m, 5H), 2.10 (s, 3H), 2.15 (s, 3H), 2.74−2.84 (m, 
1H), 3.86 (s, 3H), 4.06−4.19 (m, 1H), 4.20−4.27 (m, 1H), 4.99 (d, J = 3.0 Hz, 1H), 5.13 
(d, J = 9.8 Hz, 1H), 5.28 (s, 1H), 5.88 (d, J = 5.1 Hz, 2H), 6.36−6.42 ppm (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 20.69, 20.92, 21.01, 28.03 (3C), 33.76, 43.52, 52.12, 56.52, 
68.83, 69.05, 71.17, 79.17, 101.27, 101.90, 107.02, 134.05, 135.01, 143.41, 148.81, 
155.21, 169.20, 169.38, 170.53 ppm; IR (CHCl3): υmax = 3387, 2976, 1750, 1634, 1514 
cm-1; MS (FAB): m/z: 523 [M]+; HRMS (FAB): m/z calcd for C25H33NO11: 523.2054 
[M]+; found: 523.2070. 
 
(2S,3R,4S,4aR,11bR)-7-methoxy-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo 
[4,5-j]phenanthridine-2,3,4-triyl triacetate (22): 
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To a stirred solution of triacetate 21 (100 mg, 0.19 mmol, 1.0 equiv) in CH2Cl2 (9 mL) 
was added 2-chloropyridine (1.0 m soln. in CH2Cl2, 0.3 mL, 0.29 mmol, 1.5 equiv) and 
triflic anhydride (0.2 m soln. in CH2Cl2, 1.1. mL, 0.21 mmol, 1.1 equiv) at −78 oC. After 
stirring at −78 oC for 30 min, the reaction mixture was warmed to 35 oC and stirred for an 
additional 20 h. After that, the reaction mixture was quenched by the addition of saturated 
NaHCO3 solution at 0 oC. This was diluted with CH2Cl2, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/Acetone, 1:1) to give the major isomer 22 (65 mg, 
76%) as a white solid along with the minor isomer 23 (5 mg, 6%). [α]25D +131.3 (c = 0.15, 
CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.64 (br s, 1H), 1.85 (dt, J = 2.8, 13.6 Hz, 1H), 
2.05 (s, 6H), 2.12 (s, 3H), 2.38 (d, J = 14.4 Hz, 1H), 3.05 (dt, J = 3.8, 12.4 Hz, 1H), 3.64 
(t, J = 11.6 Hz, 1H), 4.04 (s, 3H), 5.13 (d, J = 3.0 Hz, 1H), 5,16 (d, J = 3.0 Hz, 1H), 5.40 
(t, J = 3.0 Hz, 1H), 5.98 (d, J = 7.8 Hz, 2H), 6.14 (br s, 1H), 6.44 ppm (s, 1H); 13C NMR 
(100 MHz, CDCl3): δ = 20.68, 20.76, 21.02, 26.95, 35.94, 52.12, 60.81, 67.37, 68.57, 
71.49, 98.98, 101.68, 115.51, 137.13, 137.41, 145.08, 152.06, 163.75, 169.13, 169.38, 
170.37 ppm; IR (CHCl3): υmax = 3197, 2926, 1752, 1669, 1612 cm-1; MS (FAB): m/z: 450 
[M+1]+; HRMS (FAB): m/z calcd for C21H24NO10: 450.1400 [M+H]+; found: 450.1409. 
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Characterization of isocyanate 35 
During the above reaction sequence (in this case, 1.5 equiv of Tf2O and 3.0 equiv of 2-
ClPy were used), isocyanate 35 could be obtained by quenching the reaction mixture with 
aqueous NaHCO3 solution, before raising the temperature. This was then diluted with 
CH2Cl2, washed with brine, dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by short flash chromatography on silica gel (hexane/EtOAc, 1:1) to 
give isocyanate 35. Since the compound appeared to decompose during the 
chromatography, the yield was not checked. The identity of isocyanate was confirmed by 





To a stirred solution of lactam 22 (50.0 mg, 0.11 mmol, 1.0 equiv) in MeCN (5 mL) was 
added KI (18.4 mg, 0.11 mmol, 1.0 equiv) and TMSCl (0.5 m soln. in MeCN, 0.3 mL, 
0.14 mmol, 1.3 equiv). The reaction mixture was stirred for 1 h at 60 oC and quenched by 
the addition of H2O at 0 oC. This was diluted with EtOAc, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 1:1) to give 22-OH (36.2 mg, 75%) as a 
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white solid. [α]25D +81.8 (c = 0.21, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.90 (dt, J = 
2.7, 13.5 Hz, 1H), 2.07 (s, 6H), 2.12 (s, 3H), 2.41 (d, J = 14.5 Hz, 1H), 3.12 (dt, J = 3.6, 
12.6 Hz, 1H), 3.76 (dd, J = 11.0, 12.7 Hz, 1H), 5.14−5.20 (m, 2H), 5.42 (t, J = 3.0 Hz, 
1H), 5.98 (br s, 1H), 6.02 (d, J = 4.1 Hz, 2H), 6.31 (s, 1H), 12.29 ppm (s, 1H); 13C NMR 
(75 MHz, CDCl3): δ = 20.70, 20.78, 21.03, 26.67, 34.55, 52.75, 67.23, 68.43, 71.62, 
96.71, 102.33, 106.94, 133.18, 135.78, 146.47, 152.95, 169.15, 169.33, 170.13 ppm (2C); 
IR (CHCl3): υmax = 3335, 2924, 1752, 1673, 1627 cm-1; MS (FAB): m/z: 436 [M+1]+; 
HRMS (FAB): m/z calcd for C20H22NO10: 436.1244 [M+H]+; found: 436.1245. 
To a solution of 22-OH (30.0 mg, 0.07 mmol, 1.0 equiv) in THF (7 mL) was added 
NaOMe (1.0 m soln. in MeOH, 0.7 mL, 10.0 equiv). After being stirred at room 
temperature for 1 h, the reaction was quenched by the addition of saturated NH4Cl 
solution, and extracted three times with EtOAc. The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (EtOAc/MeOH, 10:1) to give (+)-trans-dihydronarciclasine 
1 (20.3 mg, 95%) as a white solid. [α]25D +4.0 (c = 0.16, THF), (Literature.4b [α]25D +4.1 
(c = 0.22, THF)); 1H NMR (400 MHz, CD3OD): δ = 1.78−1.87 (m, 1H), 2.17−2.25 (m, 
1H), 2.99 (dt, J = 3.4, 12.6 Hz, 1H), 3.46 (dd, J = 10.1, 13.0 Hz, 1H), 3.85 (dd, J = 3.0, 
10.1 Hz, 1H), 3.90 (t, J = 2.9 Hz, 1H), 4.04−4.09 (m, 1H), 5.99 (d, J = 2.4 Hz, 2H), 6.44 
ppm (s, 1H); 13C NMR (125 MHz, CD3OD): δ = 30.43, 36.06, 57.17, 71.35, 72.33, 74.14, 
98.47, 104.22, 109.05, 134.72, 140.53, 148.06, 155.10, 172.70 ppm; IR (neat): υmax = 
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3354, 2923, 1625 cm-1; MS (FAB): m/z: 310 [M+1]+; HRMS (FAB): m/z calcd for 
C14H16NO7: 310.0927 [M+H]+; found: 310.0928. 
 35 
IV-2.2. All the compounds of the Model studies and optimization 
process  
 
IV-2.2.1. Representative procedure for preparation of N-Boc carbamate 
 
tert-Butyl (2-(7-methoxybenzo[d][1,3]dioxol-5-yl)ethyl)carbamate (25):  
NEt3 (2.9 mL, 20.5 mmol, 2.0 equiv), DMAP (125 mg, 1.03 mmol, 0.1 equiv), and 
(Boc)2O (2.5 g, 11.3 mmol, 1.1 equiv) were added to a solution of 2-(7-
methoxybenzo[d][1,3]dioxol-5-yl)ethanamine34 (2.0 g, 10.3 mmol, 1.0 equiv) in CH2Cl2 
(52 mL) at 0 °C. After stirring for 3 h at room temperature, the reaction was quenched by 
the addition of brine at 0 °C. The mixture was then extracted twice with CH2Cl2. The 
combined organic layers were washed with saturated NH4Cl solution and brine, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 2:1) to give N-Boc carbamate 25 (2.8 g, 
93%) as a white solid. 1H NMR (400 MHz, CDCl3): δ = 1.40 (s, 9H), 2.66 (t, J = 6.9 Hz, 
2H), 3.23−3.33 (m, 2H), 3.85 (s, 3H), 4.57 (br s, 1H), 5.89 (s, 2H), 6.31 (s, 1H), 6.33 (s, 
1H); 13C NMR (75 MHz, CDCl3): δ = 28.36 (3C), 36.22, 41.87, 56.48, 79.22, 101.26, 
102.75, 107.83, 133.44, 133.67, 143.52, 148.86, 155.80; IR (CHCl3): υmax = 3404, 3360, 
2974, 2936, 1709, 1510 (cm-1); HRMS (FAB): m/z calcd for C15H22NO5: 296.3389 
[M+H]+; found: 296.3396. 
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The amines required for the preparation of carbamate compounds 33a-33g, 33i, 33l, and 
33m are commercially available. Carbamate 33h were prepared from 33g by simple N-
methylation. The amines required for 33j and 33k were prepared by a previously 
developed procedure.35 
 
tert-Butyl 3,4,5-trimethoxyphenethylcarbamate (33a): 1H NMR (400 MHz, CDCl3): 
δ = 1.42 (s, 9H), 2.72 (t, J = 6.9 Hz, 2H), 3.30−3.39 (m, 2H), 3.81 (s, 3H), 3.83 (s, 6H), 
4.54 (br s, 1H), 6.38 (s, 2H); 13C NMR (75 MHz, CDCl3): δ = 28.37 (3C), 36.54, 41.72, 
56.03 (2C), 60.78, 79.21, 105.62 (2C), 134.62, 136.50, 153.21 (2C), 155.82; IR (CHCl3): 
υmax = 3371, 2974, 2937, 1711 (cm-1); HRMS (FAB): m/z calcd for C16H26NO5: 312.1811 
[M+H]+; found: 312.1820. 
 
tert-Butyl 3,4-dimethoxyphenethylcarbamate (33b): 1H NMR (300 MHz, CDCl3): δ 
= 1.41 (s, 9H), 2.71 (t, J = 7.1 Hz, 2H), 3.28−3.35 (m, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 
4.51 (br s, 1H), 6.65−6.80 (m, 3H); HRMS (FAB): m/z calcd for C15H24NO4: 282.1705 
[M+H]+; found: 282.1709. 
 
tert-Butyl (2-(benzo[d][1,3]dioxol-5-yl)ethyl)carbamate (33c): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 2.69 (t, J = 7.0 Hz, 2H), 3.27−3.35 (m, 2H), 4.51 (br s, 1H), 
5.91 (s, 2H), 6.60−6.66 (m, 2H), 6.72 (d, J = 7.9 Hz, 1H); HRMS (FAB): m/z calcd for 
C14H20NO4: 266.1392 [M+H]+; found: 266.1395. 
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tert-Butyl 3-methoxyphenethylcarbamate (33d): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.75 (t, J = 7.0 Hz, 2H), 3.33−3.37 (m, 2H), 3.78 (s, 3H), 4.52 (br s, 1H), 
6.72−6.77 (m, 3H), 7.20 (t, J = 7.8 Hz, 1H); HRMS (FAB): m/z calcd for C14H22NO3: 
252.1600 [M+H]+; found: 252.1603. 
 
tert-Butyl phenethylcarbamate (33e): 1H NMR (300 MHz, CDCl3): δ = 1.45 (s, 9H), 
2.83 (t, J = 7.3 Hz, 2H), 3.35−3.45 (m, 2H), 4.57 (br s, 1H), 7.16−7.38 (m, 5H); HRMS 
(FAB): m/z calcd for C13H20NO2: 222.1494 [M+H]+; found: 222.1490. 
 
tert-Butyl 4-chlorophenethylcarbamate (33f): 1H NMR (300 MHz, CDCl3): δ = 1.41 
(s, 9H), 2.74 (t, J = 6.9 Hz, 2H), 3.23−3.36 (m, 2H), 4.50 (br s, 1H), 7.07−7.13 (m, 2H), 
7.23−7.27 (m, 2H); HRMS (FAB): m/z calcd for C13H19ClNO2: 256.1104 [M+H]+; found: 
256.1109. 
 
tert-Butyl (2-(1H-indol-3-yl)ethyl)carbamate (33g): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.94 (t, J = 6.8 Hz, 2H), 3.38−3.51 (m, 2H), 4.60 (br s, 1H), 6.98−7.13 (m, 
1H), 7.10 (dt, J = 1.0, 7.4 Hz, 1H), 7.19 (dt, J = 1.2, 7.6 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 
7.59 (d, J = 7.7 Hz, 1H), 8.07 (br s, 1H); HRMS (FAB): m/z calcd for C15H21N2O2: 
261.1603 [M+H]+; found: 261.1608. 
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tert-Butyl (2-(1-methyl-1H-indol-3-yl)ethyl)carbamate (33h): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 2.93 (t, J = 6.8 Hz, 2H), 3.42 (br s, 2H), 3.74 (s, 3H), 4.57 (br s, 
1H), 6.87 (s, 1H), 7.07−7.11 (m, 1H), 7.19−7.30 (m, 2H), 7.57 (d, J = 7.7 Hz, 1H); 
HRMS (FAB): m/z calcd for C16H23N2O2: 275.1760 [M+H]+; found: 275.1765. 
 
tert-Butyl (2-(thiophen-3-yl)ethyl)carbamate (33i): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.80 (t, J = 6.9 Hz, 2H), 3.30−3.41 (m, 2H), 4.54 (br s, 1H), 6.92−6.98 (m, 
2H), 7.25−7.27 (m, 1H); 13C NMR (75 MHz, CDCl3): δ = 28.35 (3C), 30.65, 40.99, 79.21, 
121.25, 125.75, 128.05, 139.23, 155.80; IR (CHCl3): υmax = 3350, 2977, 2931, 1694 (cm-
1); HRMS (FAB): m/z calcd for C11H18NO2S: 228.1058 [M+H]+; found: 228.1063. 
 
tert-Butyl (3',5'-dimethoxy-[1,1'-biphenyl]-2-yl)carbamate (33j): 1H NMR (300 
MHz, CDCl3): δ = 1.45 (s, 9H), 3.80 (s, 6H), 6.48 (s, 3H), 6.60 (br s, 1H), 7.06 (dt, J = 
1.2, 7.5 Hz, 1H), 7.20 (dd, J = 1.7, 7.5 Hz, 1H) 7.32 (dt, J = 1.7, 8.4 Hz, 1H), 8.10 (d, J = 
8.3 Hz, 1H); HRMS (FAB): m/z calcd for C19H24NO4: 330.1705 [M+H]+; found: 
330.1709. 
 
tert-Butyl (3',4'-dimethoxy-[1,1'-biphenyl]-2-yl)carbamate (33k): 1H NMR (300 
MHz, CDCl3): δ = 1.45 (s, 9H), 3.88 (s, 3H), 3.93 (s, 3H), 6.54 (br s, 1H), 6.85−6.98 (m, 
3H), 7.06 (dt, J = 1.2, 7.5 Hz, 1H), 7.20 (dd, J = 1.7, 7.5 Hz, 1H) 7.30 (dt, J = 1.4, 7.1 Hz, 
1H), 8.10 (d, J = 8.3 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ = 28.30 (3C), 55.88, 55.91, 
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80.40, 111.51, 112.30, 119.55, 121.46, 122.87, 128.15, 130.05, 130.70, 130.97, 135.34, 
148.53, 149.09, 152.84; IR (CHCl3): υmax = 3345, 2977, 2934, 1730 (cm-1); HRMS 
(FAB): m/z calcd for C19H24NO4: 330.1705 [M+H]+; found: 330.1704. 
 
tert-Butyl 3,4-dimethoxybenzylcarbamate (33l): 1H NMR (300 MHz, CDCl3): δ = 
1.48 (s, 9H), 3.84 (s, 6H), 4.21 (d, J = 5.3 Hz, 2H), 4.79 (br s, 1H), 6.74−6.83 (m, 3H); 
13C NMR (75 MHz, CDCl3): δ = 28.31 (3C), 44.42, 55.72, 55.83, 79.27, 110.79, 111.09, 
119.55, 131.56, 148.20, 148.99, 155.77; IR (CHCl3): υmax = 3352, 2975, 2934, 1725 (cm-
1); HRMS (FAB): m/z calcd for C14H22NO4: 268.1549 [M+H]+; found: 268.1553. 
 
tert-Butyl (3-(3,4-dimethoxyphenyl)propyl)carbamate (33m): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 1.77 (quintet, J = 7.4 Hz, 2H), 2.57 (t, J = 7.8 Hz, 2H), 
3.05−3.20 (m, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 4.50 (br s, 1H), 6.68−6.78 (m, 3H); 13C 
NMR (75 MHz, CDCl3): δ = 28.39 (3C), 31.92, 32.68, 40.19, 55.81, 55.92, 79.11, 111.31, 
111.74, 120.13, 134.19, 147.27, 148.89, 155.95; IR (CHCl3): υmax = 3374, 2974, 2935, 
1709 (cm-1); HRMS (FAB): m/z calcd for C16H26NO4: 296.1862 [M+H]+; found: 296.1862. 
 
IV-2.2.2. Methyl (2-(7-methoxybenzo[d][1,3]dioxol-5-yl)ethyl)carbamate (26):  
NEt3 (2.9 mL, 20.5 mmol, 2.0 equiv), DMAP (125 mg, 1.03 mmol, 0.1 equiv), and 
methyl chloroformate (0.9 mL, 11.3 mmol, 1.1 equiv) were added to a solution of 2-(7-
methoxybenzo[d][1,3]dioxol-5-yl)ethanamine34 (2.0 g, 10.3 mmol, 1.0 equiv) in CH2Cl2 
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(52 mL) at 0 °C. After stirring for 3 h at room temperature, the reaction was quenched by 
the addition of brine at 0 °C. The mixture was then extracted twice with CH2Cl2. The 
combined organic layers were washed with saturated NH4Cl solution and brine, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 2:1) to give methyl carbamate 26 (2.5 g, 
95%) as a pale yellow solid. 1H NMR (400 MHz, CDCl3): δ = 2.69 (t, J = 6.8 Hz, 2H), 
3.33−3.42 (m, 2H), 3.64 (s, 3H), 3.86 (s, 3H), 4.69 (br s, 1H), 5.91 (s, 2H), 6.31 (s, 1H), 
6.34 (s, 1H); 13C NMR (75 MHz, CDCl3): δ = 36.18, 42.28, 52.03, 56.53, 101.29, 102.64, 
107.90, 133.19, 133.75, 143.56, 148.93, 156.91; IR (CHCl3): υmax = 3340, 2942, 2890, 
2843, 1697 (cm-1); HRMS (FAB): m/z calcd for C12H16NO5: 254.1028 [M+H]+; found: 
254.1025. 
 
IV-2.2.3. General procedure for the Friedel-Crafts-type cyclization associated 
with Table 1 
The specified amount of base (DMAP, pyridine, or 2-chloropyridine) and triflic 
anhydride (1.0 M soln. in CH2Cl2) was added to a stirred solution of N-Boc carbamate 25 
(89 mg, 0.30 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at the specified temperature (0 ºC or -
78 ºC). After 30 min, the reaction mixture was warmed to room temperature and stirred 
for the indicated duration. (In the case of entries 5, 6, and 7 of Table 1, Lewis acid was 
added after 20 min, stirred another 10 min and then warm to room temperature.) Then, 
the reaction mixture was quenched by the addition of saturated NaHCO3 solution at 0 ºC. 
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This solution was diluted with CH2Cl2, washed with brine, dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (CH2Cl2/MeOH, 20:1) to give the cyclized products 27 and 28 as a white solid. (When 
DMAP was replaced by the less basic pyridine or 2-chloropyridine (Table 1, entries 2 and 
3), N-triflated derivatives 30 and 31 were also generated.) Isocyanate 32 could be 
obtained by quenching the reaction mixture with aqueous NaHCO3 solution before the 
addition of Lewis acid. 
 
4-Methoxy-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-5(6H)-one (27): 1H NMR 
(400 MHz, CDCl3): δ = 2.79 (t, J = 6.4 Hz, 2H), 3.37 (dt, J = 3.6, 6.3 Hz, 2H), 4.03 (s, 
3H), 5.94 (s, 2H), 6.38 (s, 1H), 6.51 (br s, 1H); 13C NMR (100 MHz, CDCl3): δ = 30.38, 
39.69, 60.76, 101.37, 102.29, 115.68, 134.50, 137.04, 144.74, 151.26, 164.68; IR 
(CHCl3): υmax = 3406, 3221, 2929, 1664 (cm-1); HRMS (FAB): m/z calcd for C11H12NO4: 
222.0766 [M+H]+; found: 222.0761. 
 
4-Methoxy-7,8-dihydro-[1,3]dioxolo[4,5-h]isoquinolin-9(6H)-one (28): 1H NMR 
(400 MHz, CDCl3): δ = 2.86 (t, J = 6.4 Hz, 2H), 3.47 (dt, J = 2.9, 6.4 Hz, 2H), 3.91 (s, 
3H), 6.10 (s, 2H), 6.33 (s, 1H), 6.44 (br s, 1H); IR (CHCl3): υmax = 3179, 2991, 2903, 





g]isoquinolin-5(6H)-one (30): 1H NMR (400 MHz, CDCl3): δ = 2.97 (t, J = 6.0 Hz, 2H), 
4.03 (t, J = 5.9 Hz, 2H), 4.05 (s, 3H), 6.01 (s, 2H), 6.40 (s, 1H); 13C NMR (75 MHz, 
CDCl3): δ = 30.22, 46.45, 60.64, 102.09, 102.29, 117.43, 121.72, 137.26, 137.51, 146.04, 
153.72, 159.88; IR (CHCl3): υmax = 3008, 2956, 2905, 1700, 1608 (cm-1); HRMS (FAB): 
m/z calcd for C12H11F3NO6S: 354.0259 [M+H]+; found: 354.0268. 
 
4-Methoxy-8-((trifluoromethyl)sulfonyl)-7,8-dihydro-[1,3]dioxolo[4,5-
h]isoquinolin-9(6H)-one (31): 1H NMR (400 MHz, CDCl3): δ = 3.05 (t, J = 5.9 Hz, 2H), 
3.96 (s, 3H), 4.11 (t, J = 6.1 Hz, 2H), 6.14 (s, 2H), 6.36 (s, 1H); IR (CHCl3): υmax = 3010, 
2981, 2911, 1678, 1603 (cm-1); HRMS (FAB): m/z calcd for C12H11F3NO6S: 354.0259 
[M+H]+; found: 354.0265. 
 
6-(2-Isocyanatoethyl)-4-methoxybenzo[d][1,3]dioxole (32): 1H NMR (300 MHz, 
CDCl3): δ = 2.79 (t, J = 6.8 Hz, 2H), 3.46 (t, J = 6.8 Hz, 2H), 3.88 (s, 3H), 5.96 (s, 2H), 
6.36 (d, J = 1.5 Hz, 1H), 6.38 (d, J = 1.6 Hz,, 1H); IR (CHCl3): υmax = 2943, 2892, 2274, 
1634, 1512 (cm-1). 
 
IV-2.2.4. Final optimized procedure for the Friedel-Crafts-type cyclization 
utilized in Table 2 
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Method A : 2-Chloropyridine (0.45 mmol, 1.5 equiv) and triflic anhydride (0.33 mmol, 
1.1 equiv) were added to a stirred solution of N-Boc carbamate 33 (0.30 mmol, 1.0 equiv) 
in CH2Cl2 (6 mL) at -78 ºC. After 30 min, the reaction mixture was warmed to room 
temperature and stirred for 20 h. Next, the reaction mixture was quenched by the addition 
of saturated NaHCO3 solution at 0 ºC, diluted with CH2Cl2, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. This residue was purified by column 
chromatography on silica gel using an appropriate CH2Cl2/MeOH mixture as the eluent to 
yield the cyclized product 34. 
Method B : Identical to method A except for the addition of BF3·Et2O 20 min after the 
addition of Tf2O. In this case, the reaction was completed within 2 h. 
 
6,7,8-Trimethoxy-3,4-dihydroisoquinolin-1(2H)-one (34a): 1H NMR (400 MHz, 
CDCl3): δ = 2.86 (t, J = 6.3 Hz, 2H), 3.40−3.44 (m, 2H), 3.85 (s, 3H), 3.87 (s, 3H), 3.93 
(s, 3H), 6.01 (br s, 1H), 6.48 (s, 1H); HRMS (FAB): m/z calcd for C12H16NO4: 238.1079 
[M+H]+; found: 238.1083. 
 
6,7-Dimethoxy-3,4-dihydroisoquinolin-1(2H)-one (34b): 1H NMR (300 MHz, 
CDCl3): δ = 2.91 (t, J = 6.8 Hz, 2H), 3.53 (dt, J = 2.8, 6.4 Hz, 2H), 3.91 (s, 6H), 6.01 (br s, 
1H), 6.65 (s, 1H), 7.55 (s, 1H); HRMS (FAB): m/z calcd for C11H14NO3: 208.0974 
[M+H]+; found: 208.0979. 
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7,8-Dihydro-[1,3]dioxolo[4,5-g]isoquinolin-5(6H)-one (34c): 1H NMR (300 MHz 
CDCl3): δ = 2.86 (t, J = 6.6 Hz, 2H), 3.49 (t, J = 6.6 Hz, 2H), 5.97 (s, 2H), 6.62 (s, 1H), 
6.80 (br s, 1H), 7.47 (s, 1H); HRMS (FAB): m/z calcd for C10H10NO3: 192.0661 [M+H]+; 
found: 192.0657. 
 
6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one (34d): 1H NMR (400 MHz, CDCl3): δ 
= 2.94 (t, J = 6.5 Hz, 2H), 3.52 (dt, J = 2.7, 6.5 Hz, 2H), 3.83 (s, 3H), 6.11 (br s, 1H), 
6.68 (s, 1H), 6.83 (dd, J = 2.1, 8.6 Hz, 1H), 8.00 (d, J = 8.6 Hz, 1H); HRMS (FAB): m/z 
calcd for C10H12NO2: 178.0868 [M+H]+; found: 178.0873. 
 
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one (34g): 1H NMR (400 MHz, CDCl3): 
δ = 3.05 (t, J = 7.0 Hz, 2H), 3.71 (dt, J = 2.0, 6.9 Hz, 2H), 6.25 (br s, 1H), 7.12 (t, J = 7.5 
Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 8.0 Hz, 1H), 9.96 
(br s, 1H); HRMS (FAB): m/z calcd for C11H11N2O: 187.0871 [M+H]+; found: 187.0876. 
 
9-Methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one (34h): 1H NMR (400 
MHz, CDCl3): δ = 3.04 (t, J = 6.9 Hz, 2H), 3.64 (dt, J = 2.7, 6.8 Hz, 2H), 4.10 (s, 3H), 
5.57 (br s, 1H), 7.14 (dt, J = 1.1, 7.5 Hz, 1H), 7.32−7.38 (m, 2H), 7.58 (d, J = 8.0 Hz, 
1H); HRMS (FAB): m/z calcd for C12H13N2O: 201.1028 [M+H]+; found: 201.1025. 
 
5,6-Dihydrothieno[2,3-c]pyridin-7(4H)-one (34i): 1H NMR (400 MHz, CDCl3): δ = 
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2.90 (t, J = 6.9 Hz, 2H), 3.60 (dt, J = 2.2, 6.8 Hz, 2H), 6.48 (br s, 1H), 6.92 (d, J = 4.8 Hz, 
1H), 7.47 (d, J = 4.8 Hz, 1H); HRMS (FAB): m/z calcd for C7H8NOS: 154.0327 [M+H]+; 
found: 154.0328. 
 
7,9-dimethoxyphenanthridin-6(5H)-one (34j): 1H NMR (400 MHz, DMSO-d6): δ = 
3.85 (s, 3H), 3.97 (s, 3H), 6.70 (d, J = 1.7 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 
8.1 Hz, 1H), 7.41−7.48 (m, 2H), 8.32 (d, J = 8.1 Hz, 1H); HRMS (FAB): m/z calcd for 
C15H14NO3: 256.0974 [M+H]+; found: 256.0979. 
 
8,9-dimethoxyphenanthridin-6(5H)-one (34k): 1H NMR (400 MHz, DMSO-d6): δ = 
3.90 (s, 3H), 4.02 (s, 3H), 7.23 (t, J = 7.5 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 7.43 (t, J = 
7.6 Hz, 1H), 7.71 (s, 1H), 7.88 (s, 1H), 8.38 (d, J = 8.0 Hz, 1H), 11.56 (s, 1H); HRMS 
(FAB): m/z calcd for C15H14NO3: 256.0974 [M+H]+; found: 256.0978. 
 
7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (34m): 1H NMR (400 
MHz, CDCl3): δ = 1.99 (quintet, J = 6.8 Hz, 2H), 2.80 (t, J = 7.1 Hz, 2H), 3.12 (q, J = 6.4 
Hz, 2H), 3.89 (s, 3H), 3.90 (s, 3H), 6.22 (br s, 1H), 6.65 (s, 1H), 7.24 (s, 1H); HRMS 





IV-3. Analysis of molecular geometries of 15 and 16 
 
Theoretical Calculations: Theoretical calculations of regioisomers 15b (A) and 16b (B) 
were performed using the DMol3 module in Material Studio 5.5TM. The two regioisomers 
were optimized by the density functional theory (DFT) at the DNP level. A generalized 
gradient approximation (GAA) for the exchange correlation function of Perdew, Burke, 
and Ernzerhof (PBE) was used with the double-numerical plus polarization (DNP) as 
implemented in DMol3. 
The computational energy minimization using DMol3 program suggests that product 
15b is thermodynamically more stable than other conformer 16b, which is consistent with 
the experimental result. The calculated energy difference between 15b and 16b is about 
1.3586 kcal/mol. 
 
Figure 1. Density functional calculations at the PBE/DNP level on 15b and 16b. 
 
Compound Hartree (Ha) kcal/mol Relative energy (kcal/mol) 
15b -1.357390686ⅹ103 -851775.403ⅹ105 0 
16b -1.357388521ⅹ103 -851774.0444ⅹ105 1.358621 
1Ha = 627.509391 kcal/mol 
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△G = -RTlnK (R = 0.001987 kcal K-1 mol-1, T= 293.15 K) 
lnK = (-1.358621 kcal/mol) / (-0.001987 kcal K-1 mol-1ⅹ293.15 K) = 2.3324 
K = e2.3324 = 10.303 
 
Calculation input: All calculations are performed under following conditions. 
# Task parameters 
Calculate optimize 
Opt_energy_convergence 1.0000e–005 
Opt_gradient_convergence 2.0000e–003 A 
Opt_displacement_convergence 5.0000e–003 A 
Opt_iterations 50 
Opt_max_displacement 0.3000 A 
Symmetry 0ff 
Max_memory 4096 
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2D COSY NMR analysis of Enones: The chemical identities of 15a and 16a are also 
supported by the results of 2D COSY NMR experiments conducted on the corresponding 
enones 36 and 37. Enones 36 and 37 were easily synthesized from vinylogous benzyl 
esters 15a and 16a by the well-known sequence (hydride reduction and acid hydrolysis) 





enylcarbamate (36): 1H NMR (300 MHz, CDCl3): δ = 1.34 (s, 9H), 2.61−2.75 (m, 2H), 
3.11−3.25 (m, 1H), 3.88 (s, 3H), 4.56 (br s, 2H), 5.94 (s, 2H), 6.06 (d, J = 9.9 Hz, 1H), 
6.36−6.48 (m, 2H), 6.92 ppm (d, J = 9.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 
28.18 (3C), 44.96, 48.13, 56.68, 60.37, 80.16, 101.35, 101.49, 107.22, 129.22, 134.48, 
134.50, 141.61, 149.17, 152.23, 155.13, 197,54 ppm; MS (FAB): m/z: 362 [M+1]+; 
HRMS (FAB): m/z calcd for C19H24NO6: 362.1604 [M+H]+; found: 362.1609. 
tert-butyl (1R,6R)-6-(7-methoxybenzo[d][1,3]dioxol-5-yl)-2-oxocyclohex-3- 
enylcarbamate (37): 1H NMR (400 MHz, CDCl3): δ = 1.32 (s, 9H), 2.63−2.70 (m, 2H), 
3.11−3.22 (m, 1H), 3.88 (s, 3H), 4.47−4.60 (m, 1H), 4.61−4.72 (m, 1H), 5.92 (dd, J = 1.2, 
4.6 Hz, 2H), 6.14 (d, J = 10.2, Hz, 1H), 6.43−6.49 (m, 2H), 6.95 ppm (td, J = 3.7, 9.7 Hz, 
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1H); 13C NMR (100 MHz, CDCl3): δ = 28.14 (3C), 35.74, 48.29, 56.58, 60.49, 79.66, 
101.38, 101.90, 127.27, 128.76, 134.27, 134.88, 143.46, 148.40, 148.81, 155.76, 196.66 
ppm; MS (FAB): m/z: 362 [M+1]+; HRMS (FAB): m/z calcd for C19H24NO6: 362.1604 
[M+H]+; found: 362.1607. 
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국 문 초 록 
(+)-trans-Dihydronarciclasine은 Amaryllidaceae isocarbostyril 알칼로이드 계열에 
속하는 대표적인 화합물로서 다양한 암세포주에 대해 강력하고 선택적인 
항암활성을 보인다고 알려져 있다. 
본 논문은 쉽게 이용 가능한 시작물질로부터 매우 입체선택적이며 효과적인 
합성법으로 (+)-trans-dihydronarciclasine의 비대칭 전합성을 수행하는 과정에 
대해 제시하는 논문이다.  
광학적으로 순수한 시작물질인 allylic alcohol은 cross-coupling 반응과 효소에 
의한 광학분할 방법을 이용해 얻을 수 있었으며, 본 합성의 핵심 중간체인 
vinylogous ester는 allylic ester로부터 amino acid ester-enolate Claisen 
rearrangement와 위치선택적인 Wacker oxidation, Dieckmann 축합반응을 통해 
합성할 수 있었다. 이로부터 입체선택적인 산화-환원 반응을 거쳐 원하는 
입체화학을 갖는 C-ring을 합성할 수 있었다. 
특히 B-ring의 합성은 N-Boc carbamate로부터 합성된 isocyanate 중간체를 통한 
Friedel-Crafts-type 고리화 반응을 통해, 기존에 본 계열 천연물의 합성에 많이 
이용되는 Bischler-Napieralski 반응을 통한 고리화 반응의 낮은 선택성 문제를 
해결하면서 효과적으로 수행할 수 있었다. 이 과정에서 얻어진 반응 조건은 
다양한 3,4-dihydroisoquinolinone 및 관련된 heterocycle의 화합물 합성에도 응용 
가능함을 확인하였다.  
주요어: Acid-mediated cyclization, Antitumor agents, Ireland-Claisen rearrangement, 
Natural products, Total synthesis 
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Abstract 
 
We have achieved a highly stereoselective and efficient total synthesis of trans-
dihydronarciclasine from a readily available chiral starting material. Our scheme defines 
two of the five stereogenic centers of the natural product by an amino acid ester-enolate 
Claisen rearrangement. The other three stereogenic centers are created in a highly 
stereocontrolled fashion via a six-membered-ring vinylogous ester intermediate, which is 
generated from the γ,δ-unsaturated ester functional group of Claisen rearrangement 
product in an efficient three-step sequence. This concise total synthesis exemplifies the 
use of a highly regioselective Friedel-Crafts-type cyclization to form the B-ring via an 
isocyanate intermediate derived from an N-Boc group, which is superior to the 
conventional method using an imino triflate intermediate. This mild and regioselective 
reaction conditions are also applicable for synthesis of various substituted isoquinolin-1-
ones, β-carbolines, thiophen fused ring systems and tetrahydrobenzoazepin-1-ones. Acid 
additives, such as BF3·Et2O, extend the application of the method to substrates bearing 
less nucleophilic aryl moieties by enhancing the Friedel-Crafts-type cyclization of 
isocyanate intermediates. 
 
Key word: Acid-mediated cyclization, Antitumor agents, Ireland-Claisen rearrangement, 
Natural products, Total synthesis 
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I. Introduction 
 
Based on their potent and selective anticancer activity as well as their unique structural 
features, Amaryllidaceae isocarbostyril alkaloids have been an attractive synthetic target 
for the last two decades.1,2 Some representative members of this class of natural products 
are trans-dihydronarciclasine (1, Figure 1), pancratistatin (2), lycoricidine (3), and 
narciclasine (4). These natural isocarbostyrils exhibit potent cytotoxicity in the NCI 60 
human tumor cell line panel with GI50 values in the nanomolar range.3 Although trans-
dihydronarciclasine has far greater anticancer activity than the intensively investigated 
pancratistatin (2) and other congeners,3b less effort has been devoted to biological and 
synthetic studies on trans-dihydronarciclasine until recently.4 
The isolation of (+)-1 from the Chinese medical plant Zephyranthes candida was 
reported in 1990.5 Interestingly, it was produced synthetically long before its isolation 
from natural sources, through hydrogenation of narciclasine (4) with low 
diastereoselectivity.6 The first total synthesis of the racemate was reported by Cho in 
2007,4a which involved a Diels-Alder cycloaddition of 3,5-dibromo-2-pyrone for the 
preparation of functionalized C-ring. The first enantioselective synthesis by Studer 
appeared in 2008,4b in which the required absolute stereochemistry of C-ring was 
introduced by a Cu-catalyzed enantioselective nitroso Diels-Alder reaction. Both 
syntheses employed Banwell’s modified Bischler-Napieralski reaction at a late stage of 
the sequence for closure of the B-ring. 
 1 
 
Figure 1. Chemical structures of compounds 1−4. 
 
Herein, we wish to describe a short and highly stereocontrolled total synthesis of (+)-1 
by a strategy that is unique as compared to other previous syntheses of Amaryllidaceae 
isocarbostyril alkaloids. Our route is characterized by the use of an N-Boc group first to 
steer the stereochemical course of a Claisen rearrangement, and then to generate an 
isocyanate intermediate for a highly regioselective Friedel-Crafts-type B-ring cyclization. 
This approach is superior to using the conventional Bischler-Napieralski-type B-ring 
cyclization, especially in the sense of regioselectivity. 
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II. Results and Discussion 
 
II-1. Retrosynthetic Analysis 
 
As shown in Scheme 1, we planned to construct the B-ring of 1 at a late stage of the 
synthesis, similarly to many other Amaryllidaceae isocarbostyril synthetic approaches. 
We envisioned construction of the B-ring could be achieved by utilizing the N-Boc 
carbamate group in 5, where this group is also essential for attaining high stereocontrol in 
the subsequent transformations (vide infra). Our strategy was premised on the selective 
transformation the β-keto enol ether function of 6 to the three contiguous hydroxyl groups 
in the C-ring of 5. We expected that cyclic vinylogous ester 6 could be obtained 
regioselectively from the γ,δ-unsaturated ester 7 via regioselective Wacker oxidation, 
Dieckmann condensation, and regioselective vinylogous ester formation. We further 
envisioned that an ester enolate Claisen rearrangement of the Boc-protected amino acid 
allylic ester 8 would provide the γ,δ-unsaturated α-amino ester 7.7 In this transformation, 
the required stereochemistry of the two contiguous stereocenters at C-4a and C-10b could 
be installed with chirality transfer from a preformed chiral center in substrate 8 via a 
chair-like transition state. The Boc group was chosen as the amino protecting group 
because the stereoselectivity of ester enolate Claisen rearrangements of Boc-protected 
amino esters is generally superior to that of other carbamate-protected amino esters.8 In 
addition, the bulkiness of the Boc group was expected to promote high reaction 
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selectivity through steric interactions or conformational reinforcement, especially in the 
introduction of the three contiguous hydroxyl group stereocenters. 
 




II-2. A-C Ring System Synthesis 
 
As illustrated in Scheme 2, the synthesis was initiated by preparing Claisen substrate 8 
from the enantiomerically enriched allylic alcohol 9. The synthesis of 9 from the aryl 
bromide 10 and chiral building block (R)-11 (>99% ee) was previously reported by us in 
 4 
the total synthesis of 2.9 Allylic alcohol 9 was then coupled with N-Boc-glycine to 
provide the chiral allylic amino acid ester 8. After some experimentation, we identified 
conditions that led to the formation of the desired rearranged product 12 in excellent 
stereoselectivity and yield. Deprotonation of 8 at −78 oC with LHMDS in THF in the 
presence of TBSCl resulted in the formation of the intermediate (Z)-silyl ketene acetal, 
which underwent Claisen rearrangement upon gradual warming to room temperature to 
afford 12 (93%) after treatment with TMS-diazomethane.10 A single diastereomer was 
observed by NMR and HPLC analysis. The absolute configurations of the two new 
stereocenters were assumed to be 4aR and 10bR by invoking chair transition state A for 
the rearrangement, and these configurations were ultimately confirmed through 
conversion to the final natural product. 
Efforts were next directed toward forming the C-ring by a two-step process that began 
with regioselective oxidation of the internal olefin to afford methyl ketone 13. The 
resulting intermediate could then undergo Dieckmann condensation to give cyclic β-
diketone 14. In the event, highly regioselective (8:1) Wacker oxidation of olefin 12 could 
be achieved in 82% yield with Pd(OAc)2 and benzoquinone (BQ).11 Condensation of 13 
using t-BuOK in THF provided the desired β-diketone 14, which was used directly in the 








II-3. C-Ring Functionalization 
 
Our approach to functionalize the C-3 position was to convert cyclic β-diketone moiety 
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of 14 to the corresponding vinylogous ester by enol etherification. The regiochemical 
outcomes of etherification of asymmetric cyclic β-diketones are often difficult to predict, 
and mixtures of the two possible products are frequently produced.13 However, we 
envisioned that enol etherification of 14 would be regioselective under thermodynamic 
conditions, since vinylogous ester 15 was expected to be thermodynamically more stable 
than its regioisomer 16 primarily due to the lower steric strain. Some support was 
obtained from our computational modeling studies, which predicted that 15b would be 
more stable than 16b by 1.36 kcal/mol.14 As expected, treatment of crude 14 with benzyl 
alcohol and a catalytic amount of camphorsulfonic acid in toluene at 80 °C led to the 
selective formation of vinylogous benzyl ester 15a (64% yield from 13), along with a 
minor amount of its regioisomer 16a (6:1). 16a could be recycled by chromatographic 
separation followed by resubjection to the above etherification conditions to isomerize it 
back to the 6:1 mixture in favor of 15a.15 
Next, our study focused on the selective conversion of the β-keto enol ether function of 
15a into a triol (Scheme 3). First, the carbonyl group of 15a was stereoselectively 
reduced with Red-Al to give exclusively the required 4β-hydroxy group. Since allylic 
alcohol 17 was unstable,13c,16 it was immediately used in the next step without 
chromatographic purification. Dihydroxylation of the enol ether 17 under the Upjohn 
dihydroxylation conditions (OsO4, NMO)17 afforded exclusively the undesired C3-α 
stereoisomer (79% from 15a) instead of 18. Even under the hydroxy-directed 
dihydroxylation conditions of Donohoe,18 the same undesired isomer was formed (76%).  
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Scheme 3. Introduction of the stereocenters in the C ring. 
 
 
On the other hand, epoxidation of the enol ether 17 by using m-CPBA or 
VO(acac)2/TBHP system19 did occur on the desired β-face of the molecule to produce the 
α-hydroxy ketone 18 with the desired C3 stereochemistry, but in a disappointingly low 
yield (<5%). To overcome the problem of low yield, the domino epoxidation-
methanolysis protocol was employed.20 Epoxidation with m-CPBA in MeOH in the 
presence of NaHCO3 provided mixed ketal 19 as a single diastereoisomer in 82% yield (2 
steps) from 15a. Since α-hydroxy ketals are prone to rearrange under acidic conditions,21 
 8 
the deketalization of 19 was effected gently by catalytic hydrogenation of the benzyl 
group to give ketone 18. Dihydroxyketone 18 itself was also found to be unstable,22 and 
readily decomposed to unidentified polar material. Thus, the best approach was to treat 
crude ketone 18 directly with the sterically demanding L-Selectride to give triol 20 as the 
sole stereoisomer in 92% overall yield from 19.23 Triol 20 was then protected to give 
triacetate 21 (92%). 
 
 
II-4. B-Ring Construction under Banwell’s Modified Bischler-
Napieralski Reaction Conditions 
 
After completing the functionalization of the C-ring, we turned our attention to the 
construction of the B-ring to complete the total synthesis. Banwell’s modified Bischler-
Napieralski reaction,24 which is thought to proceed via an imino triflate intermediate, has 
been used widely for closure of the B-ring in the synthesis of Amaryllidaceae alkaloids 
including trans-dihydronarciclasine (1) and pancratistatin (2). However, literature 
examples of this reaction show it only to be effective for primary alkyl carbamate 
substrates.2c-e Thus, we were uncertain at that time that the Banwell procedure would be 
applicable to B-ring formation using the N-Boc group in our case. 
Under the standard Banwell’s reaction conditions (Tf2O/DMAP = 5/3 molar ratio, 0 °C), 
we were able to obtain the desired cyclization product 22 along with a minor amount of 
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the regioisomer 23 from the N-Boc carbamate 21, but in a very low yield (38%) (Scheme 
4). Interestingly, although the chemical yield was much lower (38% vs. 82%), the degree 
of regioselectivity in the B-ring formation was considerably higher than in the reported 
case in which Banwell’s modified Bischler-Napieralski reaction conditions were applied 
to the corresponding methoxycarbonyl compound 24 (11.5:1 vs. up to 3.6:1).4a,b This 
remarkable regioselectivity difference between the cyclization of substrate 21 and 24 
under the same reaction conditions implied that the two cycloaddition reactions might 
proceed via different intermediates. 
 
Scheme 4. B-ring construction under Banwell’s reaction conditions. 
 
 
Recently, Schofield and co-workers have observed that upon treatment with 2.0 equiv of 
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Tf2O and 2.2 equiv of Et3N or pyridine, N-Boc protected phenylalanine ester underwent 
dimerization to form a urea, most probably via an isocyanate intermediate.25 This 
observation suggested the possibility that under Banwell’s acidic reaction conditions, the 
N-Boc carbamate of 21 was converted to an isocyanate through loss of its acid-labile t-
butyl group and dehydration, and this in situ generated isocyanate underwent 
intramolecular Friedel-Crafts-type cyclization. Although there have been several reports 
of isocyanates being used in Friedel-Crafts-type cyclization,26 no examples of the 
intramolecular Friedel-Crafts capture of an isocyanate intermediate generated from N-Boc 
carbamates have been reported.27 Isocyanates could be prepared by several methods, such 
as from an amine by treatment with phosgene26a or its equivalent including 
(Boc)2O/DMAP,26b from an acid or amide utilizing Curtius or Hoffmann 
rearrangement,26c,d and from a carbamate by treatment with dehydrating reagents.28 
However, only a few examples of the direct conversion of N-Boc carbamate to an 
isocyanate have been reported.28a,b  
 
 
II-5. Model studies and Optimization of B–Ring Construction 
 
Based on the observation of Schofield and our initial results under Banwell’s reaction 
conditions, our studies began with the reagent combination of Tf2O and base for Friedel-
Crafts-type reactions of N-Boc carbamate substrates via isocyanate intermediateds. N-Boc 
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carbamate 25 (Scheme 5) was chosen as an initial model substrate. Before identifying the 
optimal reaction conditions for our purposes, we first examined the chemical behavior 
differences between N-Boc carbamate substrate 25 and the corresponding N-Moc 
substrate 26 under Banwell’s modified Bischler-Napieralski reaction conditions (Scheme 
5). Under the Banwell conditions, N-Boc substrate 25 provided dihydroisoquinolinone 27 
along with the minor regioisomeric product 28 in 42% combined yield and 12.2:1 
regioselectivity. On the other hand, the N-Moc substrate 26 provided a methyl imidate 29, 
which upon hydrolysis with 3 M HCl afforded 27 and 28 in a higher combined yield 
(83%) but with much lower regioselectivity (3.9:1). These results are very similar to those 
observed for the corresponding, more complex substrates 21 and 24. 
 
Scheme 5. Model Studies of B-ring Construction 
 
 
When DMAP in Banwell’s reagent combination was replaced by the less basic pyridine 
and 2-chloropyridine,29 N-Boc carbamate 25 provided 27 and 28 as well as their N-
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triflated derivatives 30 and 31 (Table 1, entries 2 and 3). The combined yield of cyclized 
products was increased, and the high regioselectivity was maintained (entries 2 and 3 vs. 
entry 1). To avoid the N-triflation caused by excess Tf2O,30 the amount of Tf2O was 
reduced to 1.5 equiv. In this case, isocyanate 32 was rapidly formed (within 20 min) as 
the only detectable reaction product and exhibited prolonged stability without conversion 
into dihydroisoquinolinones (entry 4). The identification of isocyanate 32 strengthened 
our belief that an N-Boc carbamate substrate could be transformed into a 
dihydroisoquinolinone via an isocyanate intermediate. The addition of excess Lewis acid 
(10 equiv) to the reaction mixture containing isocyanate 32 to facilitate the Friedel-Crafts 
reaction led to the formation of dihydroisoquinolinones 27 and 28 without the formation 
of the N-triflated derivatives (entries 5, 6, and 7). The yields from this stepwise process 
were much improved compared to that under the Banwell conditions (85–90% vs. 42%), 
although the degree of regioselectivity was slightly lower (8.5:1–9.7:1 vs. 12.2:1). 
The above results implied that the reaction process was greatly influenced by the amount 
of base present and the acidity of the reaction medium. By further changing the molar 
ratios of Tf2O and 2-chloropyridine, we finally determined the optimal reaction 
conditions for 25 to be 1.1 equiv of Tf2O, 1.5 equiv of 2-chloropyridine and heating at 35 
ºC for 20 h. Under these conditions, N-triflation was minimized, and the product 27 was 




Table 1. Optimization of Friedel-Crafts-type cyclizationa 
 
Entry Tf2O (eq) Base (eq) Lewis acid t (h) Yield (%)b,c (27+30): (28+31)d 
1 5.0 DMAP (3.0) – 20 42 12.2:1 
2 5.0 Py (3.0) – 20 21+(45) 12.1:1 
3 5.0 2-ClPy (3.0) – 20 44+(40) 12.4:1 
4 1.5 2-ClPy (3.0) – 20 – – 
5e 1.5 2-ClPy (3.0) BF3∙Et2O 2 86 8.5:1 
6e 1.5 2-ClPy (3.0) MsOH 0.5 90 8.5:1 
7e 1.5 2-ClPy (3.0) TfOH 0.5 85 9.7:1 
8f 1.1 2-ClPy (1.5) – 20 82 12.3:1 
aReaction conditions: 25 (0.3 mmol), Tf2O, base, CH2Cl2 (10 mL), 0 ºC for 0.5 h and then rt. bIsolated yield 
of the mixture of 27 and 28. The values in parentheses are the isolated yield of the mixture of 30 and 31. 
cEach regioisomer could be separated. dDetermined by 1H NMR analysis. eLewis acid was added after the 
formation of isocyanate. fReaction was conducted at –78 ºC for 0.5 h and then at 35 ºC for 20 h. 
 
Using the optimized reaction conditions with or without an acid additive, we next 
investigated the scope of substrates (Table 2). All substrates were first subjected to the 
reaction conditions without an acid additive (Method A: Tf2O (1.1 equiv), 2-ClPy (1.5 
equiv), –78 ºC to rt). If method A gave unsatisfactory results, the Lewis acid was added 
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after the formation of isocyanate to facilitate the Friedel-Crafts reaction (Method B: Tf2O 
(1.1 equiv), 2-ClPy (1.5 equiv), then BF3·Et2O (5.0 equiv), –78 ºC to rt). The results are 
summarized in Table 2. Remarkably, the cyclizations of all compounds bearing electron-
rich aryl rings proceeded in high yield and with high or exclusive regioselectivity. 
The N-Boc carbamate 33a bearing a trimethoxy-substituted benzene ring as a 
nucleophilic moiety was easily transformed to 3,4-dihydroisoquinolin-1-one 34a using 
method A in 71% yield (entry 1). The 3,4-dimethoxy substituted substrate 33b also 
afforded the cyclized product 34b in high yield (87%) using method A with very high 
regioselectivity (>20:1) (entry 2). However, substrates 33c and 33d required the addition 
of BF3·Et2O for cyclization (entries 3 and 4) to give products. High yield and 
regioselectivity were also observed. The Lewis acid requirement for these substrates 
might be due to the lower nucleophilicity of their aryl ring moieties compared to that of 
the electron-rich substrates 33a and 33b.31 Substrates with electron-deficient or neutral 
groups at the aryl moiety did not undergo the cyclization reaction under either set of 
reaction conditions, yielding only the corresponding isocyanates (entries 5 and 6). 
The phenyl rings could also be replaced by heteroarene units. Electron-rich heterocycles, 
such as indole and N-methyl indole moieties, showed good cyclization efficiency to 
afford tetrahyrdo-β-carbolin-1-ones 34g and 34h in good yield (70% and 92%, 
respectively) (entries 7 and 8). With the aid of an acid additive, thiopen substrate 33i also 
produced the cyclized product 34i in 79% yield (entry 9). 
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Table 2. Substrate Scope of the Reactions 























34e - A or B -d 
6 33f 
 


































aMethod A: Tf2O (1.1 equiv), 2-ClPy (1.5 equiv), CH2Cl2, –78 ºC to rt. Method B: Tf2O (1.1 equiv), 2-ClPy 
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(1.5 equiv), BF3·Et2O (5.0 equiv), CH2Cl2, –78 ºC to rt. bIsolated yield. cRegioisomeric mixture (18:1). 
dLactam product was not detected. eTfOH was used instead of BF3·Et2O. 
 
The substrate for which the N-Boc carbamate group is bonded directly to an aromatic 
ring also provided the cyclized product (entries 10 and 11). The 3,5-dimethoxy 
substituted substrate 33j smoothly afforded phenanthridone 34j in high yield (81%) under 
method A. However, the 3,4-dimethoxy substituted substrate 33k required the addition of 
the Lewis acid for cyclization and provided phenanthridone 34k in a slightly lower yield 
(70%). 
We also explored the feasibility of forming a five- or seven-membered ring lactam using 
these methods. Attempts to generate the dihydro-isoindolone 34l, from the reaction of 
substrate 33l under the above conditions produced complicated unidentified mixtures 
(entry 12).32 However, under acid-induced conditions, γ-arylpropylcarbamate 33m could 
be transformed into the benzo[c]azepin-1-one 34m in 83% yield (entry 13). 
 
 
II-6. Final Stages and Completion of the Synthesis  
 
By applying these optimized conditions to N–Boc carbamate 21, we were able to obtain 
the desired cyclization product 22 with very high regioselectivity (12.5:1) in 76% yield 
(Scheme 6). After careful monitoring of the reaction of 21, we could identify a somewhat 
unstable isocyanate intermediate 35 and its identity was mainly confirmed by IR 
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spectroscopy (2253 cm–1). The total synthesis was completed by demethylation with 
TMSCl/KI (75%) and removal of the acetate protecting groups with NaOMe (95%) to 
give (+)–1. The spectroscopic and optical rotation data of the synthetic material were in 
good agreement with those reported for the natural product. 
 






In conclusion, the total synthesis of (+)-trans-dihydronarciclasine (1) has been 
accomplished in 16% overall yield in a completely substrate-controlled manner from the 
readily accessible chiral starting material 9. One of the unique features of this synthesis is 
the highly stereocontrolled introduction of the five contiguous stereogenic centers based 
on a single stereocenter in starting material. Two of the five stereocenters were defined by 
an Ireland-Claisen rearrangement, and the other three centers were created through 
diastereoselective reduction and oxidation reactions. The stereoselectivity for introducing 
all of the stereogenic reactions was excellent, with only a single diastereomer of each 
product being observed. The concise nature of this total synthesis hinges in part on the 
first demonstration of the successful conversion of a Claisen rearrangement product into a 
six-membered cyclic vinylogous ester via a regioselective Wacker oxidation and 
Dieckmann condensation based sequence. The successful B-ring formation with high 
regioselectivity from an N-Boc substrate via an isocyanate intermediate is also quite 
noteworthy, and the present transformation is a useful complement to Banwell’s variant 






IV-1. General.  
 
All chemicals were of reagent grade and used as received. All reactions were performed 
under an inert atmosphere of dry nitrogen using distilled dry solvents. Reactions were 
monitored by TLC analysis using silica gel 60 F-254 thin layer chromatography plates. 
Flash column chromatography was carried out on silica gel (230-400 mesh). Optical 
rotations were measured using sodium light (D line 589.3 nm). 1H NMR (300, 400 or 500 
MHz) and 13C NMR (75, 100 or 125 MHz) spectra were recorded in δ units relative to the 
non-deuterated solvent as the internal reference. IR spectra were measured on a Fourier 
Transform Infrared spectrometer. Mass spectra (MS) and high resolution mass spectra 
(HRMS) were recorded using fast atom bombardment (FAB). 
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IV-2. Experimental procedure and spectroscopic data analysis 
 
IV-2.1. All the compounds of the total synthesis process 
 
(R,E)-4-(7-methoxybenzo[d][1,3]dioxol-5-yl)but-3-en-2-yl 2-(tert-butoxycarbonyl 
amino)ace tate (8): 
 
To a solution of allylic alcohol 99 (3.50 g, 15.75 mmol, 1.0 equiv) in CH2Cl2 (80 mL) 
were added N-Boc-glycine (3.31 g, 18.90 mmol, 1.2 equiv), DMAP (383 mg, 3.15 mmol, 
0.2 equiv), and DCC (3.90 g, 18.90 mmol, 1.2 equiv) at 0 °C. The reaction mixture was 
stirred for 2 h at room temperature followed by dilution with hexane. The generated white 
precipitate was removed by filtration through a pad of Celite and the filtrate was 
concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (hexane/EtOAc, 2:1) to give allylic amino acid ester 8 (5.91 
g, 99%) as a pale yellow oil. [α]25D +84.7 (c = 2.15, CHCl3); 1H NMR (400 MHz, CDCl3): 
δ = 1.37 (d, J = 6.5 Hz, 3H), 1.40 (s, 9H), 3.85 (s, 3H), 3.85−3.86 (m, 2H), 5.09 (br s, 1H), 
5.50 (pent, J = 6.5 Hz, 1H), 5.90 (s, 2H), 5.96 (dd, J = 6.9, 15.8 Hz, 1H), 6.45 (d, J = 16.0 
Hz, 1H), 6.48 (s, 1H), 6.55 ppm (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 20.25, 28.16 
(3C), 42.56, 56.39, 72.15, 79.76, 99.99, 101.43, 106.90, 126.72, 130.91, 131.87, 135.18, 
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143.43, 149.02, 155.61, 169.57 ppm; IR (CHCl3): υmax = 3399, 2979, 1713, 1627, 1510, 
1431, 1368 cm-1; MS (FAB): m/z: 379 [M]+; HRMS (FAB): m/z calcd for C19H25NO7: 





To a stirred solution of ester 8 (5.00 g, 13.18 mmol, 1.0 equiv) in THF (80 mL) was 
added TBSCl (5.96 g, 39.54 mmol, 3.0 equiv) in THF (8 mL). After the mixture was 
cooled to –78 oC, LHMDS (1.0 m soln. in THF, 40 mL, 39.54 mmol, 3.0 equiv) was 
slowly added to the reaction flask over 30 min. The reaction mixture was slowly warmed 
to room temperature and stirred for 20 h. The reaction was quenched with saturated 
NH4Cl solution at 0 oC, stirred for another 1 h at room temperature, and then the mixture 
was extracted twice with EtOAc. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated under reduced pressure to give the desired acid 12-
acid as a single isomer, which was used in the next step without further purification. A 
small amount of pure acid was isolated by column chromatography on silica gel 
(hexane/EtOAc, 2:1 + 1% AcOH) for 1H NMR and HRMS analysis. 1H NMR (400 MHz, 
CD3OD): δ = 1.33 (s, 9H), 1.65 (d, J = 5.9 Hz, 3H), 3.52 (t, J = 8.6 Hz, 1H), 3.85 (s, 3H), 
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4.34 (d, J = 8.8 Hz, 1H), 5.50−5.58 (m, 1H), 5.60−5.67 (m, 1H), 5.86 (d, J = 3.4 Hz, 2H), 
6.42 (s, 1H), 6.44 ppm (s, 1H); MS (FAB): m/z: 402 [M+23]+; HRMS (FAB): m/z calcd 
for C19H25NO7: 379.1631 [M]+; found: 379.1655. 
The crude mixture obtained above was dissolved in MeOH (44 mL), and trimethylsilyl-
diazomethane solution (2.0 m soln. in diethyl ether, 17 mL, 32.95 mmol, 2.5 equiv) was 
added dropwise, causing instantaneous bubbling, along with a change from colorless to 
yellow. After allowing the reaction to proceed for 1 h, the reaction was quenched with 
small amount of acetic acid, at which time gas evolved and the reaction mixture became 
colorless. The solvent was removed in vacuo, and the residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 4:1) to give the desired ester 12 
(4.82 g, 93% for 2 steps) as a pale yellow solid. [α]25D −45.2 (c = 0.88, CHCl3); 1H NMR 
(500 MHz, CDCl3): δ = 1.38 (s, 9H), 1.67 (d, J = 5.1 Hz, 3H), 3.54−3.50 (m, 1H), 3.66 (s, 
3H), 3.87 (s, 3H), 4.50 (t, J = 7.3 Hz, 1H), 4.78 (d, J = 7.6 Hz, 1H), 5.54−5.63 (m, 2H), 
5.92 (s, 2H), 6.31 (s, 1H), 6.36 ppm (d, J = 1.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ = 
17.81, 28.02 (3C), 51.16, 51.71, 56.44, 57.76, 79.77, 101.23, 101.80, 107.36, 128.24, 
128.87, 133.95, 134.10, 143.38, 148.88, 155.07, 172.02 ppm; IR (CHCl3): υmax = 3377, 
2976, 1744, 1715, 1634, 1510, 1452 cm-1; MS (FAB): m/z: 394 [M+1]+; HRMS (FAB): 
m/z calcd for C20H28NO7: 394.1866 [M+H]+; found: 394.1972. 
The diastereomeric purity of ester 12 was determined by crude 1H NMR spectrum 
analysis. The enantiomeric purity of ester 12 (>99%ee) was determined by chiral HPLC 
analysis (CHIRALCEL OJ-H, 2-propanol/hexane (0 to 10%, 60 min), flow rate: 0.5 
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mL/min, tR: (chiral sample) = 37.7 min [(–)-isomer]; tR (racemic sample) = 37.1 [(–)-





To a mixture of Pd(OAc)2 (685 mg, 3.05 mmol, 0.3 equiv) and 1,4-benzoquinone (1.10 
g, 10.17 mmol, 1.0 equiv) in MeCN/H2O (7:1, v/v, 51 mL) was added HClO4 (1.0 m soln. 
in MeCN, 2.0 mL, 2.03 mmol, 0.2 equiv). The resulting solution was stirred 1 h at room 
temperature and ester 12 (4.00 g, 10.17 mmol, 1.0 equiv) was added to reaction flask. 
After being stirred for 6 h at room temperature, the reaction was quenched with saturated 
NaHCO3 solution at 0 oC and then the mixture was extracted twice with EtOAc. The 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo. Due to similar Rf values for the hydroquinone generated and the product under 
various eluent conditions, hydroquinone was acetylated under standard conditions (Ac2O, 
NEt3, DMAP, CH2Cl2). The resulting crude mixture was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 2:1) to give desired methyl ketone 13 (3.41 
g, 82%) as a pale brown oil. [α]25D −55.3 (c = 0.72, CHCl3); 1H NMR (500 MHz, CDCl3): 
δ = 1.43 (s, 9H), 2.13 (s, 3H), 2.67 (dd, J = 5.4, 17.7 Hz, 1H), 2.98 (dd, J = 8.4, 17.8 Hz, 
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1H), 3.70 (s, 3H), 3.78 (br s, 1H), 3.86 (s, 3H), 4.60 (d, J = 5.0 Hz, 1H), 4.97 (d, J = 8.3 
Hz, 1H), 5.92 (s, 2H), 6.26 (d, J = 1.3 Hz, 1H), 6.31 ppm (d, J = 1.4 Hz, 1H); 13C NMR 
(125 MHz, CDCl3): δ = 28.14 (3C), 30.14, 42.25, 45.14, 52.10, 56.47, 56.58, 79.96, 
101.31, 101.64, 108.10, 133.00, 134.46, 143.30, 148.94, 155.70, 171.40, 205.80 ppm; IR 
(CHCl3): υmax = 3381, 2978, 1714, 1633, 1510, 1452, 1435 cm-1; MS (FAB): m/z: 409 





To a stirred solution of methyl ketone 13 (3.00 g, 7.33 mmol, 1.0 equiv) in THF (40 mL) 
was slowly added t-BuOK (1.0 m soln. in THF, 19 mL, 18.3 mmol, 2.5 equiv) at 0 oC. 
The reaction mixture was stirred for 30 min at 0 oC, then quenched by addition of 
saturated NH4Cl solution, and extracted twice with EtOAc. The combined organic layers 
were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to give β-





Vinylogous benzyl ester (15a and 16a): 
 
To a mixture of crude β-diketone 14 in toluene (30 mL) and benzyl alcohol (7.5 mL), 
catalytic 10-camphorsulfonic acid (170 mg, 0.73 mmol, 0.1 equiv) was added. The 
reaction mixture was stirred for 4 h at 80 oC and then quenched by the addition of NEt3 
(0.1 mL) at 0 oC. This was diluted with EtOAc, washed with brine, dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (hexane/EtOAc, 2:1) to give vinylogous benzyl ester 15a (2.19 g, 64%) and 
minor isomer 16a (377 mg, 11%) as white solids. The minor isomer 16a could be cleanly 
separated chromatographically and be isomerized back to the 6:1 mixture (combined 70% 
yield) in favor of 15a by resubjection to the above etherification conditions. Additional 
15a (226 mg) could be obtained from 16a through this isomerization. 
 
Major isomer 15a (tert-butyl (1R,6R)-4-(benzyloxy)-6-(7-methoxybenzo[d][1,3]dioxol-
5-yl)-2-oxocyclohex-3-enylcarbamate): [α]25D +21.6 (c = 0.67, CHCl3); 1H NMR (400 
MHz, CDCl3): δ = 1.30 (s, 9H), 2.66 (dd, J = 4.7, 17.5 Hz, 1H), 2.81−2.89 (m, 1H), 3.21 
(t, J = 8.6 Hz, 1H), 3.84 (s, 3H), 4.25−4.38 (m, 1H), 4.75−4.90 (m, 3H), 5.55 (s, 1H), 
5.87 (d, J = 2.3 Hz, 2H), 6.42 (s, 1H), 6.45 (s, 1H), 7.29−7.36 ppm (m, 5H); 13C NMR 
(100 MHz, CDCl3): δ = 28.01 (3C), 37.65, 45.95, 56.41, 59.58, 70.86, 79.30, 101.20, 
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101.70, 101.88, 107.20, 127.63 (2C), 128.48, 128.59 (2C), 134.11, 134.54, 134.59, 
143.30, 148.65, 155.73, 174.82, 194.95 ppm; IR (CHCl3): υmax = 2977, 1708, 1665, 1608, 
1514, 1453, 1364 cm-1; MS (FAB): m/z: 468 [M+1]+; HRMS (FAB): m/z calcd for 
C26H30NO7: 468.2022 [M+H]+; found: 468.2010. 
 
Minor isomer 16a (tert-butyl (1R,6R)-2-(benzyloxy)-6-(7-methoxybenzo[d][1,3]dioxol-
5-yl)-4-oxocyclohex-2-enylcarbamate): 1H NMR (500 MHz, DMSO-d6): δ = 1.25 (s, 
9H), 2.36 (dd, J = 3.9, 16.1 Hz, 1H), 2.78 (dd, J = 13.4, 16.0 Hz, 1H), 3.29−3.39 (m, 1H), 
3.80 (s, 3H), 4.66 (t, J = 9.9 Hz, 1H), 4.97−5.03 (m, 2H), 5.50 (s, 1H), 5.94 (s, 2H), 6.59 





To a stirred solution of vinylogous benzyl ester 15a (2.00 g, 4.28 mmol, 1.0 equiv) in 
THF (43 mL) was slowly added Red-Al (sodium bis(2-methoxyethoxy)aluminum 
dihydride (70% in toluene, ca. 3.6 m), 1.8 mL, 6.42 mmol, 1.5 equiv) at 0 oC. The 
reaction mixture was stirred for additional 30 min, and then quenched by the addition of 
saturated NH4Cl solution at 0 oC, and extracted twice with EtOAc. The combined organic 
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layers were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to 
give allylic alcohol 17 as a single isomer.33 Due to its instability under acidic conditions, 
the resulting pale yellow oil was used in the next step without further purification. The 
diastereomeric purity of alcohol 17 was determined by crude 1H NMR spectrum analysis. 
1H NMR (300 MHz, CDCl3): δ = 1.35 (s, 9H), 2.40 (dd, J = 5.1, 16.8 Hz, 1H), 2.52 (t, J = 
16.8 Hz, 1H), 2.89 (dt, J = 5.5, 11.5 Hz, 1H), 3.69 (td, J = 7.1, 11.8 Hz, 1H), 3.89 (s, 3H), 
4.41 (br s, 2H), 4.67−4.90 (m, 3H), 5.90−6.00 (m, 2H), 6.38−6.44 (m, 2H), 7.27−7.42 





To the crude mixture of allylic alcohol 17 obtained in the previous step in MeOH (22 
mL) was added NaHCO3 (1.08 g, 12.84 mmol, 3.0 equiv) and m-CPBA (1.11 g, 6.42 
mmol, 1.5 equiv) at 0 oC. The reaction mixture was stirred for 2 h at room temperature, 
and then quenched by addition of saturated Na2S2O3 solution at 0 oC, and extracted twice 
with EtOAc. The combined organic layers were washed with brine, dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (hexane/EtOAc, 1:2) to give ketal 19 (1.82 g, 82% for 2 steps from 15a) as a 
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single isomer. [α]25D +11.8 (c = 0.51, CHCl3); 1H NMR (400 MHz, CDCl3 + D2O): δ = 
1.29 (s, 9H), 2.02 (dd, J = 2.0, 13.9 Hz, 1H), 2.12 (t, J = 13.9 Hz, 1H), 2.51 (dt, J = 3.5, 
12.5 Hz, 1H), 3.27 (s, 3H), 3.73 (dd, J = 2.5, 9.8 Hz, 1H), 3.86 (s, 3H), 3.91 (br s, 1H), 
4.13 (s, 1H), 4.38 (d, J = 7.9 Hz, 1H), 4.50 (d, J = 11.4 Hz, 1H), 4.59 (d, J = 11.4 Hz, 1H), 
5.90 (d, J = 3.2 Hz, 2H), 6.40 (d, J = 3.8 Hz, 2H), 7.26−7.38 ppm (m, 5H); 13C NMR 
(100 MHz, CDCl3): δ = 28.07 (3C), 34.95, 43.21, 47.81, 54.94, 56.46, 62.33, 70.87, 73.64, 
79.77, 100.99, 101.19, 101.97, 106.77, 127.33, 127.42 (2C), 128.26 (2C), 133.89, 135.89, 
138.08, 143.49, 148.71, 157.19 ppm; IR (CHCl3): υmax = 3398, 2973, 1691, 1635, 1515 
cm-1; MS (FAB): m/z: 518 [M+1]+; HRMS (FAB): m/z calcd for C27H36NO9: 518.2390 





To a solution of 19 (1.50 g, 2.90 mol, 1.0 equiv) in MeOH (30 mL) was added 10% 
Pd/C (450 mg, 30% wt. of 19). The flask was evacuated, filled with H2, and stirred at 
room temperature for 5 h. After this, the reaction mixture was diluted with EtOAc, 
filtered through a pad of Celite, and concentrated in vacuo to give crude mixture of 
dihydroxyketone 18. Due to its instability, resulting colorless oil was used in the next step 
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without further purification. To the crude mixture of 18 in THF (30 mL) was slowly 
added L-Selectride (lithium tri-sec-butylborohydride, 1.0 m soln. in THF, 4.4 mL, 4.35 
mmol, 1.5 equiv) at −78 oC. The reaction mixture was stirred for 30 min at -78 oC, and 
then quenched by addition of saturated NH4Cl solution at 0 oC, and extracted twice with 
EtOAc. The combined organic layers were washed with brine, dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (hexane/Acetone, 1:2) to give triol 20 (1.06 g, 92% for 2 steps from 19) as a single 
isomer. [α]25D +0.99 (c = 0.65, CH3OH); 1H NMR (400 MHz, CD3OD): δ = 1.25 (s, 9H), 
1.71 (d, J = 13.6 Hz, 1H), 2.10 (t, J = 13.2 Hz, 1H), 2.86 (t, J = 11.0 Hz, 1H), 3.34 (s, 1H), 
3.70−3.78 (m, 1H), 3.81 (s, 1H), 3.85 (s, 3H), 3.95 (s, 2H), 5.80−5.86 (m, 2H), 6.44 (s, 
1H), 6.49 ppm (s, 1H); 13C NMR (100 MHz, CD3OD): δ = 29.47 (3C), 37.08, 44.65, 
56.77, 57.89, 71.52, 73.56, 75.01, 80.34, 102.95, 103.98, 109.91, 135.68, 139.56, 145.36, 
150.76, 159.41 ppm; IR (neat): υmax = 3388, 2925, 1683, 1635, 1513 cm-1; MS (FAB): 
m/z: 397 [M]+; HRMS (FAB): m/z calcd for C19H27NO8: 397.1737 [M]+; found 397.1753. 
 
(1S,2R,3S,4R,5R)-4-(tert-butoxycarbonylamino)-5-(7-methoxybenzo[d][1,3]dioxol-
5-yl)cyclohexane-1,2,3-triyl triacetate (21): 
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To a mixture of triol 20 (700 mg, 1.76 mmol, 1.0 equiv) in CH2Cl2 (18 mL) was added 
NEt3 (2.0 mL, 14.08 mmol, 8.0 equiv), DMAP (21.5 mg, 0.176 mmol, 0.1 equiv), and 
Ac2O (0.84 mL, 8.81 mmol, 5.0 equiv) at 0 oC. After being stirred for 3 h at room 
temperature, the reaction was quenched by addition brine at 0 oC and then the mixture 
was extracted twice with CH2Cl2. The combined organic layers were washed with 
saturated NH4Cl and brine, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by flash chromatography on silica gel (hexane/EtOAc, 1:1) to give triacetate 
21 (848 mg, 92%) as a colorless oil. [α]25D +44.4 (c = 0.64, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ = 1.23 (br s, 9H), 1.90−2.02 (m, 5H), 2.10 (s, 3H), 2.15 (s, 3H), 2.74−2.84 (m, 
1H), 3.86 (s, 3H), 4.06−4.19 (m, 1H), 4.20−4.27 (m, 1H), 4.99 (d, J = 3.0 Hz, 1H), 5.13 
(d, J = 9.8 Hz, 1H), 5.28 (s, 1H), 5.88 (d, J = 5.1 Hz, 2H), 6.36−6.42 ppm (m, 2H); 13C 
NMR (100 MHz, CDCl3): δ = 20.69, 20.92, 21.01, 28.03 (3C), 33.76, 43.52, 52.12, 56.52, 
68.83, 69.05, 71.17, 79.17, 101.27, 101.90, 107.02, 134.05, 135.01, 143.41, 148.81, 
155.21, 169.20, 169.38, 170.53 ppm; IR (CHCl3): υmax = 3387, 2976, 1750, 1634, 1514 
cm-1; MS (FAB): m/z: 523 [M]+; HRMS (FAB): m/z calcd for C25H33NO11: 523.2054 
[M]+; found: 523.2070. 
 
(2S,3R,4S,4aR,11bR)-7-methoxy-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo 
[4,5-j]phenanthridine-2,3,4-triyl triacetate (22): 
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To a stirred solution of triacetate 21 (100 mg, 0.19 mmol, 1.0 equiv) in CH2Cl2 (9 mL) 
was added 2-chloropyridine (1.0 m soln. in CH2Cl2, 0.3 mL, 0.29 mmol, 1.5 equiv) and 
triflic anhydride (0.2 m soln. in CH2Cl2, 1.1. mL, 0.21 mmol, 1.1 equiv) at −78 oC. After 
stirring at −78 oC for 30 min, the reaction mixture was warmed to 35 oC and stirred for an 
additional 20 h. After that, the reaction mixture was quenched by the addition of saturated 
NaHCO3 solution at 0 oC. This was diluted with CH2Cl2, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/Acetone, 1:1) to give the major isomer 22 (65 mg, 
76%) as a white solid along with the minor isomer 23 (5 mg, 6%). [α]25D +131.3 (c = 0.15, 
CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.64 (br s, 1H), 1.85 (dt, J = 2.8, 13.6 Hz, 1H), 
2.05 (s, 6H), 2.12 (s, 3H), 2.38 (d, J = 14.4 Hz, 1H), 3.05 (dt, J = 3.8, 12.4 Hz, 1H), 3.64 
(t, J = 11.6 Hz, 1H), 4.04 (s, 3H), 5.13 (d, J = 3.0 Hz, 1H), 5,16 (d, J = 3.0 Hz, 1H), 5.40 
(t, J = 3.0 Hz, 1H), 5.98 (d, J = 7.8 Hz, 2H), 6.14 (br s, 1H), 6.44 ppm (s, 1H); 13C NMR 
(100 MHz, CDCl3): δ = 20.68, 20.76, 21.02, 26.95, 35.94, 52.12, 60.81, 67.37, 68.57, 
71.49, 98.98, 101.68, 115.51, 137.13, 137.41, 145.08, 152.06, 163.75, 169.13, 169.38, 
170.37 ppm; IR (CHCl3): υmax = 3197, 2926, 1752, 1669, 1612 cm-1; MS (FAB): m/z: 450 
[M+1]+; HRMS (FAB): m/z calcd for C21H24NO10: 450.1400 [M+H]+; found: 450.1409. 
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Characterization of isocyanate 35 
During the above reaction sequence (in this case, 1.5 equiv of Tf2O and 3.0 equiv of 2-
ClPy were used), isocyanate 35 could be obtained by quenching the reaction mixture with 
aqueous NaHCO3 solution, before raising the temperature. This was then diluted with 
CH2Cl2, washed with brine, dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by short flash chromatography on silica gel (hexane/EtOAc, 1:1) to 
give isocyanate 35. Since the compound appeared to decompose during the 
chromatography, the yield was not checked. The identity of isocyanate was confirmed by 





To a stirred solution of lactam 22 (50.0 mg, 0.11 mmol, 1.0 equiv) in MeCN (5 mL) was 
added KI (18.4 mg, 0.11 mmol, 1.0 equiv) and TMSCl (0.5 m soln. in MeCN, 0.3 mL, 
0.14 mmol, 1.3 equiv). The reaction mixture was stirred for 1 h at 60 oC and quenched by 
the addition of H2O at 0 oC. This was diluted with EtOAc, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 1:1) to give 22-OH (36.2 mg, 75%) as a 
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white solid. [α]25D +81.8 (c = 0.21, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.90 (dt, J = 
2.7, 13.5 Hz, 1H), 2.07 (s, 6H), 2.12 (s, 3H), 2.41 (d, J = 14.5 Hz, 1H), 3.12 (dt, J = 3.6, 
12.6 Hz, 1H), 3.76 (dd, J = 11.0, 12.7 Hz, 1H), 5.14−5.20 (m, 2H), 5.42 (t, J = 3.0 Hz, 
1H), 5.98 (br s, 1H), 6.02 (d, J = 4.1 Hz, 2H), 6.31 (s, 1H), 12.29 ppm (s, 1H); 13C NMR 
(75 MHz, CDCl3): δ = 20.70, 20.78, 21.03, 26.67, 34.55, 52.75, 67.23, 68.43, 71.62, 
96.71, 102.33, 106.94, 133.18, 135.78, 146.47, 152.95, 169.15, 169.33, 170.13 ppm (2C); 
IR (CHCl3): υmax = 3335, 2924, 1752, 1673, 1627 cm-1; MS (FAB): m/z: 436 [M+1]+; 
HRMS (FAB): m/z calcd for C20H22NO10: 436.1244 [M+H]+; found: 436.1245. 
To a solution of 22-OH (30.0 mg, 0.07 mmol, 1.0 equiv) in THF (7 mL) was added 
NaOMe (1.0 m soln. in MeOH, 0.7 mL, 10.0 equiv). After being stirred at room 
temperature for 1 h, the reaction was quenched by the addition of saturated NH4Cl 
solution, and extracted three times with EtOAc. The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (EtOAc/MeOH, 10:1) to give (+)-trans-dihydronarciclasine 
1 (20.3 mg, 95%) as a white solid. [α]25D +4.0 (c = 0.16, THF), (Literature.4b [α]25D +4.1 
(c = 0.22, THF)); 1H NMR (400 MHz, CD3OD): δ = 1.78−1.87 (m, 1H), 2.17−2.25 (m, 
1H), 2.99 (dt, J = 3.4, 12.6 Hz, 1H), 3.46 (dd, J = 10.1, 13.0 Hz, 1H), 3.85 (dd, J = 3.0, 
10.1 Hz, 1H), 3.90 (t, J = 2.9 Hz, 1H), 4.04−4.09 (m, 1H), 5.99 (d, J = 2.4 Hz, 2H), 6.44 
ppm (s, 1H); 13C NMR (125 MHz, CD3OD): δ = 30.43, 36.06, 57.17, 71.35, 72.33, 74.14, 
98.47, 104.22, 109.05, 134.72, 140.53, 148.06, 155.10, 172.70 ppm; IR (neat): υmax = 
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3354, 2923, 1625 cm-1; MS (FAB): m/z: 310 [M+1]+; HRMS (FAB): m/z calcd for 
C14H16NO7: 310.0927 [M+H]+; found: 310.0928. 
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IV-2.2. All the compounds of the Model studies and optimization 
process  
 
IV-2.2.1. Representative procedure for preparation of N-Boc carbamate 
 
tert-Butyl (2-(7-methoxybenzo[d][1,3]dioxol-5-yl)ethyl)carbamate (25):  
NEt3 (2.9 mL, 20.5 mmol, 2.0 equiv), DMAP (125 mg, 1.03 mmol, 0.1 equiv), and 
(Boc)2O (2.5 g, 11.3 mmol, 1.1 equiv) were added to a solution of 2-(7-
methoxybenzo[d][1,3]dioxol-5-yl)ethanamine34 (2.0 g, 10.3 mmol, 1.0 equiv) in CH2Cl2 
(52 mL) at 0 °C. After stirring for 3 h at room temperature, the reaction was quenched by 
the addition of brine at 0 °C. The mixture was then extracted twice with CH2Cl2. The 
combined organic layers were washed with saturated NH4Cl solution and brine, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 2:1) to give N-Boc carbamate 25 (2.8 g, 
93%) as a white solid. 1H NMR (400 MHz, CDCl3): δ = 1.40 (s, 9H), 2.66 (t, J = 6.9 Hz, 
2H), 3.23−3.33 (m, 2H), 3.85 (s, 3H), 4.57 (br s, 1H), 5.89 (s, 2H), 6.31 (s, 1H), 6.33 (s, 
1H); 13C NMR (75 MHz, CDCl3): δ = 28.36 (3C), 36.22, 41.87, 56.48, 79.22, 101.26, 
102.75, 107.83, 133.44, 133.67, 143.52, 148.86, 155.80; IR (CHCl3): υmax = 3404, 3360, 
2974, 2936, 1709, 1510 (cm-1); HRMS (FAB): m/z calcd for C15H22NO5: 296.3389 
[M+H]+; found: 296.3396. 
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The amines required for the preparation of carbamate compounds 33a-33g, 33i, 33l, and 
33m are commercially available. Carbamate 33h were prepared from 33g by simple N-
methylation. The amines required for 33j and 33k were prepared by a previously 
developed procedure.35 
 
tert-Butyl 3,4,5-trimethoxyphenethylcarbamate (33a): 1H NMR (400 MHz, CDCl3): 
δ = 1.42 (s, 9H), 2.72 (t, J = 6.9 Hz, 2H), 3.30−3.39 (m, 2H), 3.81 (s, 3H), 3.83 (s, 6H), 
4.54 (br s, 1H), 6.38 (s, 2H); 13C NMR (75 MHz, CDCl3): δ = 28.37 (3C), 36.54, 41.72, 
56.03 (2C), 60.78, 79.21, 105.62 (2C), 134.62, 136.50, 153.21 (2C), 155.82; IR (CHCl3): 
υmax = 3371, 2974, 2937, 1711 (cm-1); HRMS (FAB): m/z calcd for C16H26NO5: 312.1811 
[M+H]+; found: 312.1820. 
 
tert-Butyl 3,4-dimethoxyphenethylcarbamate (33b): 1H NMR (300 MHz, CDCl3): δ 
= 1.41 (s, 9H), 2.71 (t, J = 7.1 Hz, 2H), 3.28−3.35 (m, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 
4.51 (br s, 1H), 6.65−6.80 (m, 3H); HRMS (FAB): m/z calcd for C15H24NO4: 282.1705 
[M+H]+; found: 282.1709. 
 
tert-Butyl (2-(benzo[d][1,3]dioxol-5-yl)ethyl)carbamate (33c): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 2.69 (t, J = 7.0 Hz, 2H), 3.27−3.35 (m, 2H), 4.51 (br s, 1H), 
5.91 (s, 2H), 6.60−6.66 (m, 2H), 6.72 (d, J = 7.9 Hz, 1H); HRMS (FAB): m/z calcd for 
C14H20NO4: 266.1392 [M+H]+; found: 266.1395. 
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tert-Butyl 3-methoxyphenethylcarbamate (33d): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.75 (t, J = 7.0 Hz, 2H), 3.33−3.37 (m, 2H), 3.78 (s, 3H), 4.52 (br s, 1H), 
6.72−6.77 (m, 3H), 7.20 (t, J = 7.8 Hz, 1H); HRMS (FAB): m/z calcd for C14H22NO3: 
252.1600 [M+H]+; found: 252.1603. 
 
tert-Butyl phenethylcarbamate (33e): 1H NMR (300 MHz, CDCl3): δ = 1.45 (s, 9H), 
2.83 (t, J = 7.3 Hz, 2H), 3.35−3.45 (m, 2H), 4.57 (br s, 1H), 7.16−7.38 (m, 5H); HRMS 
(FAB): m/z calcd for C13H20NO2: 222.1494 [M+H]+; found: 222.1490. 
 
tert-Butyl 4-chlorophenethylcarbamate (33f): 1H NMR (300 MHz, CDCl3): δ = 1.41 
(s, 9H), 2.74 (t, J = 6.9 Hz, 2H), 3.23−3.36 (m, 2H), 4.50 (br s, 1H), 7.07−7.13 (m, 2H), 
7.23−7.27 (m, 2H); HRMS (FAB): m/z calcd for C13H19ClNO2: 256.1104 [M+H]+; found: 
256.1109. 
 
tert-Butyl (2-(1H-indol-3-yl)ethyl)carbamate (33g): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.94 (t, J = 6.8 Hz, 2H), 3.38−3.51 (m, 2H), 4.60 (br s, 1H), 6.98−7.13 (m, 
1H), 7.10 (dt, J = 1.0, 7.4 Hz, 1H), 7.19 (dt, J = 1.2, 7.6 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 
7.59 (d, J = 7.7 Hz, 1H), 8.07 (br s, 1H); HRMS (FAB): m/z calcd for C15H21N2O2: 
261.1603 [M+H]+; found: 261.1608. 
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tert-Butyl (2-(1-methyl-1H-indol-3-yl)ethyl)carbamate (33h): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 2.93 (t, J = 6.8 Hz, 2H), 3.42 (br s, 2H), 3.74 (s, 3H), 4.57 (br s, 
1H), 6.87 (s, 1H), 7.07−7.11 (m, 1H), 7.19−7.30 (m, 2H), 7.57 (d, J = 7.7 Hz, 1H); 
HRMS (FAB): m/z calcd for C16H23N2O2: 275.1760 [M+H]+; found: 275.1765. 
 
tert-Butyl (2-(thiophen-3-yl)ethyl)carbamate (33i): 1H NMR (300 MHz, CDCl3): δ = 
1.42 (s, 9H), 2.80 (t, J = 6.9 Hz, 2H), 3.30−3.41 (m, 2H), 4.54 (br s, 1H), 6.92−6.98 (m, 
2H), 7.25−7.27 (m, 1H); 13C NMR (75 MHz, CDCl3): δ = 28.35 (3C), 30.65, 40.99, 79.21, 
121.25, 125.75, 128.05, 139.23, 155.80; IR (CHCl3): υmax = 3350, 2977, 2931, 1694 (cm-
1); HRMS (FAB): m/z calcd for C11H18NO2S: 228.1058 [M+H]+; found: 228.1063. 
 
tert-Butyl (3',5'-dimethoxy-[1,1'-biphenyl]-2-yl)carbamate (33j): 1H NMR (300 
MHz, CDCl3): δ = 1.45 (s, 9H), 3.80 (s, 6H), 6.48 (s, 3H), 6.60 (br s, 1H), 7.06 (dt, J = 
1.2, 7.5 Hz, 1H), 7.20 (dd, J = 1.7, 7.5 Hz, 1H) 7.32 (dt, J = 1.7, 8.4 Hz, 1H), 8.10 (d, J = 
8.3 Hz, 1H); HRMS (FAB): m/z calcd for C19H24NO4: 330.1705 [M+H]+; found: 
330.1709. 
 
tert-Butyl (3',4'-dimethoxy-[1,1'-biphenyl]-2-yl)carbamate (33k): 1H NMR (300 
MHz, CDCl3): δ = 1.45 (s, 9H), 3.88 (s, 3H), 3.93 (s, 3H), 6.54 (br s, 1H), 6.85−6.98 (m, 
3H), 7.06 (dt, J = 1.2, 7.5 Hz, 1H), 7.20 (dd, J = 1.7, 7.5 Hz, 1H) 7.30 (dt, J = 1.4, 7.1 Hz, 
1H), 8.10 (d, J = 8.3 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ = 28.30 (3C), 55.88, 55.91, 
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80.40, 111.51, 112.30, 119.55, 121.46, 122.87, 128.15, 130.05, 130.70, 130.97, 135.34, 
148.53, 149.09, 152.84; IR (CHCl3): υmax = 3345, 2977, 2934, 1730 (cm-1); HRMS 
(FAB): m/z calcd for C19H24NO4: 330.1705 [M+H]+; found: 330.1704. 
 
tert-Butyl 3,4-dimethoxybenzylcarbamate (33l): 1H NMR (300 MHz, CDCl3): δ = 
1.48 (s, 9H), 3.84 (s, 6H), 4.21 (d, J = 5.3 Hz, 2H), 4.79 (br s, 1H), 6.74−6.83 (m, 3H); 
13C NMR (75 MHz, CDCl3): δ = 28.31 (3C), 44.42, 55.72, 55.83, 79.27, 110.79, 111.09, 
119.55, 131.56, 148.20, 148.99, 155.77; IR (CHCl3): υmax = 3352, 2975, 2934, 1725 (cm-
1); HRMS (FAB): m/z calcd for C14H22NO4: 268.1549 [M+H]+; found: 268.1553. 
 
tert-Butyl (3-(3,4-dimethoxyphenyl)propyl)carbamate (33m): 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (s, 9H), 1.77 (quintet, J = 7.4 Hz, 2H), 2.57 (t, J = 7.8 Hz, 2H), 
3.05−3.20 (m, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 4.50 (br s, 1H), 6.68−6.78 (m, 3H); 13C 
NMR (75 MHz, CDCl3): δ = 28.39 (3C), 31.92, 32.68, 40.19, 55.81, 55.92, 79.11, 111.31, 
111.74, 120.13, 134.19, 147.27, 148.89, 155.95; IR (CHCl3): υmax = 3374, 2974, 2935, 
1709 (cm-1); HRMS (FAB): m/z calcd for C16H26NO4: 296.1862 [M+H]+; found: 296.1862. 
 
IV-2.2.2. Methyl (2-(7-methoxybenzo[d][1,3]dioxol-5-yl)ethyl)carbamate (26):  
NEt3 (2.9 mL, 20.5 mmol, 2.0 equiv), DMAP (125 mg, 1.03 mmol, 0.1 equiv), and 
methyl chloroformate (0.9 mL, 11.3 mmol, 1.1 equiv) were added to a solution of 2-(7-
methoxybenzo[d][1,3]dioxol-5-yl)ethanamine34 (2.0 g, 10.3 mmol, 1.0 equiv) in CH2Cl2 
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(52 mL) at 0 °C. After stirring for 3 h at room temperature, the reaction was quenched by 
the addition of brine at 0 °C. The mixture was then extracted twice with CH2Cl2. The 
combined organic layers were washed with saturated NH4Cl solution and brine, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 2:1) to give methyl carbamate 26 (2.5 g, 
95%) as a pale yellow solid. 1H NMR (400 MHz, CDCl3): δ = 2.69 (t, J = 6.8 Hz, 2H), 
3.33−3.42 (m, 2H), 3.64 (s, 3H), 3.86 (s, 3H), 4.69 (br s, 1H), 5.91 (s, 2H), 6.31 (s, 1H), 
6.34 (s, 1H); 13C NMR (75 MHz, CDCl3): δ = 36.18, 42.28, 52.03, 56.53, 101.29, 102.64, 
107.90, 133.19, 133.75, 143.56, 148.93, 156.91; IR (CHCl3): υmax = 3340, 2942, 2890, 
2843, 1697 (cm-1); HRMS (FAB): m/z calcd for C12H16NO5: 254.1028 [M+H]+; found: 
254.1025. 
 
IV-2.2.3. General procedure for the Friedel-Crafts-type cyclization associated 
with Table 1 
The specified amount of base (DMAP, pyridine, or 2-chloropyridine) and triflic 
anhydride (1.0 M soln. in CH2Cl2) was added to a stirred solution of N-Boc carbamate 25 
(89 mg, 0.30 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at the specified temperature (0 ºC or -
78 ºC). After 30 min, the reaction mixture was warmed to room temperature and stirred 
for the indicated duration. (In the case of entries 5, 6, and 7 of Table 1, Lewis acid was 
added after 20 min, stirred another 10 min and then warm to room temperature.) Then, 
the reaction mixture was quenched by the addition of saturated NaHCO3 solution at 0 ºC. 
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This solution was diluted with CH2Cl2, washed with brine, dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel (CH2Cl2/MeOH, 20:1) to give the cyclized products 27 and 28 as a white solid. (When 
DMAP was replaced by the less basic pyridine or 2-chloropyridine (Table 1, entries 2 and 
3), N-triflated derivatives 30 and 31 were also generated.) Isocyanate 32 could be 
obtained by quenching the reaction mixture with aqueous NaHCO3 solution before the 
addition of Lewis acid. 
 
4-Methoxy-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-5(6H)-one (27): 1H NMR 
(400 MHz, CDCl3): δ = 2.79 (t, J = 6.4 Hz, 2H), 3.37 (dt, J = 3.6, 6.3 Hz, 2H), 4.03 (s, 
3H), 5.94 (s, 2H), 6.38 (s, 1H), 6.51 (br s, 1H); 13C NMR (100 MHz, CDCl3): δ = 30.38, 
39.69, 60.76, 101.37, 102.29, 115.68, 134.50, 137.04, 144.74, 151.26, 164.68; IR 
(CHCl3): υmax = 3406, 3221, 2929, 1664 (cm-1); HRMS (FAB): m/z calcd for C11H12NO4: 
222.0766 [M+H]+; found: 222.0761. 
 
4-Methoxy-7,8-dihydro-[1,3]dioxolo[4,5-h]isoquinolin-9(6H)-one (28): 1H NMR 
(400 MHz, CDCl3): δ = 2.86 (t, J = 6.4 Hz, 2H), 3.47 (dt, J = 2.9, 6.4 Hz, 2H), 3.91 (s, 
3H), 6.10 (s, 2H), 6.33 (s, 1H), 6.44 (br s, 1H); IR (CHCl3): υmax = 3179, 2991, 2903, 





g]isoquinolin-5(6H)-one (30): 1H NMR (400 MHz, CDCl3): δ = 2.97 (t, J = 6.0 Hz, 2H), 
4.03 (t, J = 5.9 Hz, 2H), 4.05 (s, 3H), 6.01 (s, 2H), 6.40 (s, 1H); 13C NMR (75 MHz, 
CDCl3): δ = 30.22, 46.45, 60.64, 102.09, 102.29, 117.43, 121.72, 137.26, 137.51, 146.04, 
153.72, 159.88; IR (CHCl3): υmax = 3008, 2956, 2905, 1700, 1608 (cm-1); HRMS (FAB): 
m/z calcd for C12H11F3NO6S: 354.0259 [M+H]+; found: 354.0268. 
 
4-Methoxy-8-((trifluoromethyl)sulfonyl)-7,8-dihydro-[1,3]dioxolo[4,5-
h]isoquinolin-9(6H)-one (31): 1H NMR (400 MHz, CDCl3): δ = 3.05 (t, J = 5.9 Hz, 2H), 
3.96 (s, 3H), 4.11 (t, J = 6.1 Hz, 2H), 6.14 (s, 2H), 6.36 (s, 1H); IR (CHCl3): υmax = 3010, 
2981, 2911, 1678, 1603 (cm-1); HRMS (FAB): m/z calcd for C12H11F3NO6S: 354.0259 
[M+H]+; found: 354.0265. 
 
6-(2-Isocyanatoethyl)-4-methoxybenzo[d][1,3]dioxole (32): 1H NMR (300 MHz, 
CDCl3): δ = 2.79 (t, J = 6.8 Hz, 2H), 3.46 (t, J = 6.8 Hz, 2H), 3.88 (s, 3H), 5.96 (s, 2H), 
6.36 (d, J = 1.5 Hz, 1H), 6.38 (d, J = 1.6 Hz,, 1H); IR (CHCl3): υmax = 2943, 2892, 2274, 
1634, 1512 (cm-1). 
 
IV-2.2.4. Final optimized procedure for the Friedel-Crafts-type cyclization 
utilized in Table 2 
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Method A : 2-Chloropyridine (0.45 mmol, 1.5 equiv) and triflic anhydride (0.33 mmol, 
1.1 equiv) were added to a stirred solution of N-Boc carbamate 33 (0.30 mmol, 1.0 equiv) 
in CH2Cl2 (6 mL) at -78 ºC. After 30 min, the reaction mixture was warmed to room 
temperature and stirred for 20 h. Next, the reaction mixture was quenched by the addition 
of saturated NaHCO3 solution at 0 ºC, diluted with CH2Cl2, washed with brine, dried over 
MgSO4, filtered, and concentrated in vacuo. This residue was purified by column 
chromatography on silica gel using an appropriate CH2Cl2/MeOH mixture as the eluent to 
yield the cyclized product 34. 
Method B : Identical to method A except for the addition of BF3·Et2O 20 min after the 
addition of Tf2O. In this case, the reaction was completed within 2 h. 
 
6,7,8-Trimethoxy-3,4-dihydroisoquinolin-1(2H)-one (34a): 1H NMR (400 MHz, 
CDCl3): δ = 2.86 (t, J = 6.3 Hz, 2H), 3.40−3.44 (m, 2H), 3.85 (s, 3H), 3.87 (s, 3H), 3.93 
(s, 3H), 6.01 (br s, 1H), 6.48 (s, 1H); HRMS (FAB): m/z calcd for C12H16NO4: 238.1079 
[M+H]+; found: 238.1083. 
 
6,7-Dimethoxy-3,4-dihydroisoquinolin-1(2H)-one (34b): 1H NMR (300 MHz, 
CDCl3): δ = 2.91 (t, J = 6.8 Hz, 2H), 3.53 (dt, J = 2.8, 6.4 Hz, 2H), 3.91 (s, 6H), 6.01 (br s, 
1H), 6.65 (s, 1H), 7.55 (s, 1H); HRMS (FAB): m/z calcd for C11H14NO3: 208.0974 
[M+H]+; found: 208.0979. 
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7,8-Dihydro-[1,3]dioxolo[4,5-g]isoquinolin-5(6H)-one (34c): 1H NMR (300 MHz 
CDCl3): δ = 2.86 (t, J = 6.6 Hz, 2H), 3.49 (t, J = 6.6 Hz, 2H), 5.97 (s, 2H), 6.62 (s, 1H), 
6.80 (br s, 1H), 7.47 (s, 1H); HRMS (FAB): m/z calcd for C10H10NO3: 192.0661 [M+H]+; 
found: 192.0657. 
 
6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one (34d): 1H NMR (400 MHz, CDCl3): δ 
= 2.94 (t, J = 6.5 Hz, 2H), 3.52 (dt, J = 2.7, 6.5 Hz, 2H), 3.83 (s, 3H), 6.11 (br s, 1H), 
6.68 (s, 1H), 6.83 (dd, J = 2.1, 8.6 Hz, 1H), 8.00 (d, J = 8.6 Hz, 1H); HRMS (FAB): m/z 
calcd for C10H12NO2: 178.0868 [M+H]+; found: 178.0873. 
 
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one (34g): 1H NMR (400 MHz, CDCl3): 
δ = 3.05 (t, J = 7.0 Hz, 2H), 3.71 (dt, J = 2.0, 6.9 Hz, 2H), 6.25 (br s, 1H), 7.12 (t, J = 7.5 
Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 8.0 Hz, 1H), 9.96 
(br s, 1H); HRMS (FAB): m/z calcd for C11H11N2O: 187.0871 [M+H]+; found: 187.0876. 
 
9-Methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one (34h): 1H NMR (400 
MHz, CDCl3): δ = 3.04 (t, J = 6.9 Hz, 2H), 3.64 (dt, J = 2.7, 6.8 Hz, 2H), 4.10 (s, 3H), 
5.57 (br s, 1H), 7.14 (dt, J = 1.1, 7.5 Hz, 1H), 7.32−7.38 (m, 2H), 7.58 (d, J = 8.0 Hz, 
1H); HRMS (FAB): m/z calcd for C12H13N2O: 201.1028 [M+H]+; found: 201.1025. 
 
5,6-Dihydrothieno[2,3-c]pyridin-7(4H)-one (34i): 1H NMR (400 MHz, CDCl3): δ = 
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2.90 (t, J = 6.9 Hz, 2H), 3.60 (dt, J = 2.2, 6.8 Hz, 2H), 6.48 (br s, 1H), 6.92 (d, J = 4.8 Hz, 
1H), 7.47 (d, J = 4.8 Hz, 1H); HRMS (FAB): m/z calcd for C7H8NOS: 154.0327 [M+H]+; 
found: 154.0328. 
 
7,9-dimethoxyphenanthridin-6(5H)-one (34j): 1H NMR (400 MHz, DMSO-d6): δ = 
3.85 (s, 3H), 3.97 (s, 3H), 6.70 (d, J = 1.7 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 
8.1 Hz, 1H), 7.41−7.48 (m, 2H), 8.32 (d, J = 8.1 Hz, 1H); HRMS (FAB): m/z calcd for 
C15H14NO3: 256.0974 [M+H]+; found: 256.0979. 
 
8,9-dimethoxyphenanthridin-6(5H)-one (34k): 1H NMR (400 MHz, DMSO-d6): δ = 
3.90 (s, 3H), 4.02 (s, 3H), 7.23 (t, J = 7.5 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 7.43 (t, J = 
7.6 Hz, 1H), 7.71 (s, 1H), 7.88 (s, 1H), 8.38 (d, J = 8.0 Hz, 1H), 11.56 (s, 1H); HRMS 
(FAB): m/z calcd for C15H14NO3: 256.0974 [M+H]+; found: 256.0978. 
 
7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (34m): 1H NMR (400 
MHz, CDCl3): δ = 1.99 (quintet, J = 6.8 Hz, 2H), 2.80 (t, J = 7.1 Hz, 2H), 3.12 (q, J = 6.4 
Hz, 2H), 3.89 (s, 3H), 3.90 (s, 3H), 6.22 (br s, 1H), 6.65 (s, 1H), 7.24 (s, 1H); HRMS 





IV-3. Analysis of molecular geometries of 15 and 16 
 
Theoretical Calculations: Theoretical calculations of regioisomers 15b (A) and 16b (B) 
were performed using the DMol3 module in Material Studio 5.5TM. The two regioisomers 
were optimized by the density functional theory (DFT) at the DNP level. A generalized 
gradient approximation (GAA) for the exchange correlation function of Perdew, Burke, 
and Ernzerhof (PBE) was used with the double-numerical plus polarization (DNP) as 
implemented in DMol3. 
The computational energy minimization using DMol3 program suggests that product 
15b is thermodynamically more stable than other conformer 16b, which is consistent with 
the experimental result. The calculated energy difference between 15b and 16b is about 
1.3586 kcal/mol. 
 
Figure 1. Density functional calculations at the PBE/DNP level on 15b and 16b. 
 
Compound Hartree (Ha) kcal/mol Relative energy (kcal/mol) 
15b -1.357390686ⅹ103 -851775.403ⅹ105 0 
16b -1.357388521ⅹ103 -851774.0444ⅹ105 1.358621 
1Ha = 627.509391 kcal/mol 
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△G = -RTlnK (R = 0.001987 kcal K-1 mol-1, T= 293.15 K) 
lnK = (-1.358621 kcal/mol) / (-0.001987 kcal K-1 mol-1ⅹ293.15 K) = 2.3324 
K = e2.3324 = 10.303 
 
Calculation input: All calculations are performed under following conditions. 
# Task parameters 
Calculate optimize 
Opt_energy_convergence 1.0000e–005 
Opt_gradient_convergence 2.0000e–003 A 
Opt_displacement_convergence 5.0000e–003 A 
Opt_iterations 50 
Opt_max_displacement 0.3000 A 
Symmetry 0ff 
Max_memory 4096 
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2D COSY NMR analysis of Enones: The chemical identities of 15a and 16a are also 
supported by the results of 2D COSY NMR experiments conducted on the corresponding 
enones 36 and 37. Enones 36 and 37 were easily synthesized from vinylogous benzyl 
esters 15a and 16a by the well-known sequence (hydride reduction and acid hydrolysis) 





enylcarbamate (36): 1H NMR (300 MHz, CDCl3): δ = 1.34 (s, 9H), 2.61−2.75 (m, 2H), 
3.11−3.25 (m, 1H), 3.88 (s, 3H), 4.56 (br s, 2H), 5.94 (s, 2H), 6.06 (d, J = 9.9 Hz, 1H), 
6.36−6.48 (m, 2H), 6.92 ppm (d, J = 9.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 
28.18 (3C), 44.96, 48.13, 56.68, 60.37, 80.16, 101.35, 101.49, 107.22, 129.22, 134.48, 
134.50, 141.61, 149.17, 152.23, 155.13, 197,54 ppm; MS (FAB): m/z: 362 [M+1]+; 
HRMS (FAB): m/z calcd for C19H24NO6: 362.1604 [M+H]+; found: 362.1609. 
tert-butyl (1R,6R)-6-(7-methoxybenzo[d][1,3]dioxol-5-yl)-2-oxocyclohex-3- 
enylcarbamate (37): 1H NMR (400 MHz, CDCl3): δ = 1.32 (s, 9H), 2.63−2.70 (m, 2H), 
3.11−3.22 (m, 1H), 3.88 (s, 3H), 4.47−4.60 (m, 1H), 4.61−4.72 (m, 1H), 5.92 (dd, J = 1.2, 
4.6 Hz, 2H), 6.14 (d, J = 10.2, Hz, 1H), 6.43−6.49 (m, 2H), 6.95 ppm (td, J = 3.7, 9.7 Hz, 
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1H); 13C NMR (100 MHz, CDCl3): δ = 28.14 (3C), 35.74, 48.29, 56.58, 60.49, 79.66, 
101.38, 101.90, 127.27, 128.76, 134.27, 134.88, 143.46, 148.40, 148.81, 155.76, 196.66 
ppm; MS (FAB): m/z: 362 [M+1]+; HRMS (FAB): m/z calcd for C19H24NO6: 362.1604 
[M+H]+; found: 362.1607. 
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국 문 초 록 
(+)-trans-Dihydronarciclasine은 Amaryllidaceae isocarbostyril 알칼로이드 계열에 
속하는 대표적인 화합물로서 다양한 암세포주에 대해 강력하고 선택적인 
항암활성을 보인다고 알려져 있다. 
본 논문은 쉽게 이용 가능한 시작물질로부터 매우 입체선택적이며 효과적인 
합성법으로 (+)-trans-dihydronarciclasine의 비대칭 전합성을 수행하는 과정에 
대해 제시하는 논문이다.  
광학적으로 순수한 시작물질인 allylic alcohol은 cross-coupling 반응과 효소에 
의한 광학분할 방법을 이용해 얻을 수 있었으며, 본 합성의 핵심 중간체인 
vinylogous ester는 allylic ester로부터 amino acid ester-enolate Claisen 
rearrangement와 위치선택적인 Wacker oxidation, Dieckmann 축합반응을 통해 
합성할 수 있었다. 이로부터 입체선택적인 산화-환원 반응을 거쳐 원하는 
입체화학을 갖는 C-ring을 합성할 수 있었다. 
특히 B-ring의 합성은 N-Boc carbamate로부터 합성된 isocyanate 중간체를 통한 
Friedel-Crafts-type 고리화 반응을 통해, 기존에 본 계열 천연물의 합성에 많이 
이용되는 Bischler-Napieralski 반응을 통한 고리화 반응의 낮은 선택성 문제를 
해결하면서 효과적으로 수행할 수 있었다. 이 과정에서 얻어진 반응 조건은 
다양한 3,4-dihydroisoquinolinone 및 관련된 heterocycle의 화합물 합성에도 응용 
가능함을 확인하였다.  
주요어: Acid-mediated cyclization, Antitumor agents, Ireland-Claisen rearrangement, 
Natural products, Total synthesis 
학  번: 2007-21826 
 102 
